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Cattle and African buffaloes are major maintenance hosts of Mycobacterium bovis in South Africa 
and therefore serve as a potential source of infection for other animals and humans. 
Mycobacterium bovis is the causative agent of bovine tuberculosis (BTB). Identification and 
removal of M. bovis-infected animals from the herd at early stages of infection is important for 
effective disease management and relies on the strategic application of ante-mortem diagnostic 
tests. Ante-mortem diagnostic tests rely on the detection of specific immunological responses in 
the animal. However, these responses vary over the course of infection and therefore the accuracy 
of the diagnostic test may change, depending on the stage of infection. We therefore aimed to 
investigate the temporal changes in antigen-specific cytokine production and humoral responses to 
BTB in buffaloes. Interferon-gamma (IFN-ɣ) and IFN-ɣ-induced protein 10 (IP-10) production in 
response to mycobacterial antigens ESAT-6/CFP-10, and serum antibodies to bovine purified 
protein derivative (bPPD) were measured in a group of chronically test-positive, newly converted 
test-positive and test-negative buffaloes over one year. No consistent trends in immune responses 
over time were observed in any of the groups.  
Cytokine release assays (CRAs) are often used in conjunction with the tuberculin skin test (TST) to 
improve diagnostic performance. However, many studies have shown that the TST may influence 
IFN-ɣ production and thereby the outcome of immunodiagnostic tests in cattle. However, these 
results were conflicting. A better understanding of the influence of the TST on cytokine production 
and the duration of this effect in a South African situation is required. We therefore aimed to 
investigate if the TST has an influence on IFN-ɣ and IP-10 production and test outcome in cattle 
and African buffaloes. IFN-ɣ and IP-10 release were measured in response to bPPD, avian PPD, 
ESAT-6 and CFP-10 in groups of TST-positive cattle 6, 7, 21, 41 and 78 days post-TST and in a 
group of TST-negative cattle 7, 21 and 78 days post-TST.  IFN-ɣ and IP-10 levels in response to 
PPD were elevated 1-3 weeks post-TST, followed by a decrease by 41 days, suggesting immune 
boosting by the TST. ESAT-6/CFP-10-specific cytokine release showed conflicting results, with a 
group of animals showing decreased cytokine production by 41 days, whereas another group 
showed no change in cytokine release over time. Our findings suggest that cattle should not be 
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tested with CRAs between 6 and 41 days post-TST to avoid boosting of cytokine levels and 
inaccurate test results.  
IFN-ɣ and IP-10 release in response to PC-EC®, PC-HP®, bPPD and avian PPD were measured 
in a group of Bovigam®-positive and negative buffaloes at the time the TST was performed and 
three days later. In Bovigam®-positive buffaloes a significant decrease in cytokine production and 
in the proportion of test positive animals were observed three days post-TST in response to all 
antigens, except aPPD. Bovigam®-negative animals were not influenced by the TST. It is therefore 
recommended that buffaloes should be sampled pre-TST to identify all possible M. bovis-positive 
animals in this herd of high BTB incidence.   
Accuracy of diagnostic assays may be affected by many factors, including the immunological stage 
of M. bovis-infection, time interval between the performance of the TST and CRA, exposure to 
environmental mycobacteria and BTB incidence in the herd. The correct application and 
interpretation of diagnostic assays of high specificity and sensitivity is required to overcome some 
of these factors. Therefore, information of the BTB status of the herd, exposure to environmental 
mycobacteria, and an understanding of the aim of the disease management plan is required.   
  




Beeste en Afrika buffels is belangrike onderhouds gaste van Mycobacterium bovis in Suid Afrika 
en dien daarom as ‘n bron van infeksie vir ander diere. Hierdie patogeen is die oorsaak van bees 
tuberkulose (BTB) en indentifisering en verwydering van M. bovis-geïnfekteerde diere uit die kudde 
in ‘n vroeë stadium van infeksie is belangrik vir effektiewe siekte beheer. Dit is afhanklik van die 
strategiese aanwending van ante mortem diagnostiese toetse. Daarom, vir die verbetering van 
toets interpretasie, was ons doel om die temporale veranderinge in antigeen-spesifieke sitokien 
produksie en humorale reaksies tot BTB in buffels te ondersoek. Interferon-gamma (IFN-ɣ) en IFN-
ɣ-geïnduseerde proteïen 10 (IP-10) produksie in reaksie tot mikobakteriële antigene ESAT-6/CFP-
10, en teenliggaam vlakke was bepaal in ‘n groep chronies Bovigam®-positiewe (n = 5), pas 
omgeskakelde Bovigam®-positiewe (n = 5) en Bovigam®-negatiewe buffels (n = 8) oor ‘n 1 jaar 
typerk. Daar was geen spesifieke patrone in immuun reaksies oor tyd in enige van die groepe nie, 
alhoewel die chronies Bovigam®-positiewe diere ESAT-6/CFP-10 positief gebly het. ‘n Een jaar 
studie tydperk was nie genoeg om veranderinge in sitokien en teenliggaam vlakke in natuurlik-
geïnfekteerde buffels te evalueer nie.  
IFN-ɣ vrystellings toetse (IGRAs) word algemeen saam met die tuberkulien vel toets (TST) gebruik 
om die diagnostiese prestasie te verbeter. Baie studies het egter bevind dat die TST ‘n effek op in 
vitro IFN-ɣ produksie in beeste het. Daarom was die doel van die studie om die effek van die TST 
op sitokien produksie en toets sensitiwiteit, spesifisiteit en resultaat in beeste en buffels te bepaal. 
Vrystelling van IFN-ɣ en IP-10 was bepaal in reaksie tot PPDs, ESAT-6 en CFP-10 in ‘n groep 
TST-positiewe beeste 6 en 41 dae na die TST (groep 1). Soortgelyk, was sitokien vrystelling in 
TST-positiewe en negatiewe beeste by 7, 21 en 78 dae na die TST (groep 2) bepaal. IFN-ɣ and IP-
10 vlakke in reaksie tot PPD was verhoog 1-3 weke na die TST, gevolg deur ‘n afname teen 41 
dae, wat dui op ‘n immunologiese “boosting” deur die TST. Sitokien produksie in respons tot 
ESAT-6/CFP-10 in group 1 het ook betekenisvol afgeneem. Sitokien “boosting” mag egter verband 
hou met blootstelling aan omgewings mikobakterieë in hierdie kudde met ‘n lae voorkoms van 
BTB. Ons resultate ondersteun die gebruik van toetse wat ESAT-6/CFP-10 gebruik om beeste 
rondom 41 dae na die TST te toets en so die akkuraatheid van die toets resultate te verbeter.  
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IFN-ɣ en IP-10 vrystelling in respons tot PC-EC, PC-HP, bovine PPD en avian PPD was bepaal in 
‘n groep Bovigam®-positiewe en negatiewe buffels op dieselfde tyd van die uitvoer van die TST en 
3 dae later. Sitokien produksie en die proporsie toets-positiewe diere het betekenisvol afgeneem 3 
dae na die TST in respons tot al die antigene, behalwe avian PPD, in Bovigam®-positiewe buffels. 
Dit word daarom aanbeveel dat bloedmonsters geneem moet word wanneer die TST uitgevoer 
word om al die TST-positiewe buffels te identifiseer.  
Akkuraatheid van diagnostiese toetse kan deur vele faktore geaffekteer word, insluitend die 
immunologiese stadium van M. bovis-infeksie, tyd interval tussen die TST en sitokien toetse, 
blootstelling aan omgewings mikobakterieë, en die BTB voorkoms in die kudde. Die korrekte 
aanwending en interpreatsie van diagnostiese toetse met hoë sensitiwiteit en spesifisiteit word 
benodig om sommige van die faktore te oorkom. Inligting van the BTB voorkoms in die kudde, en 
die blootstelling aan omgewings mikobakterieë asook ‘n begrip van die doel van die spesifieke 
siekte beheer plan is daarom belangrik.    
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Chapter 1: Introduction 
Mycobacterium bovis is the causative agent of bovine tuberculosis (BTB), a chronic infectious 
disease that affects livestock and wildlife, and its zoonotic potential presents a risk to public health 
(Buddle et al., 2009; Renwick et al., 2007). M. bovis is a member of the Mycobacterium 
tuberculosis complex, a group of genetically related mycobacteria that cause tuberculosis (TB) in a 
wide range of hosts (Huard et al., 2006). In South Africa, M. bovis was first identified as early as 
1880 in cattle, whereas the first case of BTB in wildlife was diagnosed in 1928 (Renwick et al., 
2007). Maintenance hosts of M. bovis, such as cattle and African buffaloes, in an area is of 
particular concern for BTB management programs, since these animals allow persistence of 
infection and serve as a source of infection to many other animals, including lions, warthogs, 
bushbuck and kudus (Palmer et al., 2012; Renwick et al., 2007). These animals may be infected 
with M. bovis long before showing signs of disease (De Vos et al., 2001). Therefore, early 
diagnosis, accurate detection and removal of M. bovis-infected animals are important to prevent 
disease transmission and to support adequate disease management practices (Buddle et al., 2009; 
de la Rua-Domenech et al., 2006). Accurate diagnostic assays are thus essential. Ante-mortem 
diagnostic assays typically rely on detection of specific immunological responses, such as in vitro 
antigen-specific cytokine release or delayed-type hypersensitivity (DTH) responses for the 
tuberculin skin test (TST) (Welsh et al., 2005). However, immunological responses in cattle 
infected with M. bovis have been reported to change over time, which may affect the accuracy of 
diagnostic tests, depending on the stage of infection or disease progression (Rhodes et al., 2000a, 
2000b, 2000c; Welsh et al., 2005). For this reason a greater understanding of the changes in 
immunological responses over the course of infection is required to interpret test results. However, 
this has not been thoroughly investigated in wildlife, specifically in African buffaloes. Therefore, we 
aimed to investigate the changes in antigen-specific cytokine production and humoral responses to 
BTB in M. bovis-infected African buffaloes over time and determine the temporal relationships of 
different biomarkers of BTB. This will provide information on how diagnostic tests and their 
interpretation may be influenced by disease progression in buffaloes. More accurate test 
interpretation will improve the outcome of disease management programs.  
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Interferon-gamma release assays (IGRAs) are often used in conjunction with TSTs for the 
diagnosis of M. bovis infection in animals (de la Rua-Domenech et al., 2006). However, many 
studies have shown that interferon gamma (IFN-ɣ) production is affected by the purified protein 
derivative (PPD) injection used for performing TSTs in cattle. Literature has shown conflicting 
observations regarding IFN-ɣ release following the TST (de la Rua-Domenech et al., 2006; 
Gormley et al., 2006; Palmer et al., 2006; Ryan et al., 2000). In some studies, the TST has been 
shown to boost IFN-ɣ production to aid in identification of M. bovis-infected animals, especially 
those with low IFN-ɣ responses in early stages of disease (Palmer et al., 2006). The effect of the 
TST on IFN-ɣ-induced protein 10 (IP-10) production, a sensitive diagnostic biomarker with 
promising results in buffaloes (Goosen et al., 2015) and cattle (Parsons et al., 2016), has not been 
examined. Therefore, we aimed to investigate the effect of the TST on IFN-ɣ and IP-10 production 
in response to sensitive and specific antigens at various time points following the TST in a group of 
cattle originating from a low BTB prevalence herd in South African conditions. Also, since the effect 
of the TST on cytokine production has not been investigated in African buffaloes, we aimed to 
examine the changes in IFN-ɣ and IP-10 production following the TST in these animals. 
Furthermore, we aimed to determine whether the assay result, sensitivity, or specificity will be 
affected by the TST in buffaloes and cattle. A greater understanding of the effect of the TST on 
cytokine release assays (CRAs) will provide new information on the optimal time interval required 
between the performance of the TST and CRAs to improve the diagnosis of M. bovis infection in 
cattle and buffaloes.  
Problem statement 
Bovine TB management programs on cattle and buffaloes rely on ante-mortem diagnostic assays 
to identify M. bovis-positive animals at an early stage of infection. Removal of these animals from 
the herd will prevent further transmission. However, to conduct these assays at the proper time 
points and interpret the results correctly, a better understanding of the temporal immunological 
changes in M. bovis-infected animals are needed. More information on the changes in cell-
mediated immune (CMI) and humoral responses and how these responses correlate with disease 
progression is required in buffaloes to identify how this may impact diagnostic tests. Furthermore, 
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serial testing with TSTs followed by CRAs have been shown to influence CRA results. A better 
understanding of the effect of the TST and the duration of that effect is needed for buffaloes and 
cattle, since this may significantly influence the outcome of diagnostic tests and effective disease 
management. More information on the duration of the TST effect will contribute to defining the 
optimal amount of time required between TSTs and CRAs for serial testing in herds.  
Aims and objectives 
 To investigate changes in antigen-specific cytokine production over time in M. bovis-
infected buffaloes 
 To investigate the changes in serological responses to M. bovis antigens over time in M. 
bovis-infected buffaloes 
 To determine the temporal relationship of different BTB biomarkers over time 
 To determine the effect of the TST on cytokine production in M. bovis-infected buffaloes  
 To determine the effect of the TST on cytokine production in M. bovis-uninfected buffaloes 
and cattle 
 To investigate the effect of the TST on sensitivity, specificity and test outcome in M. bovis-
infected and uninfected buffaloes and cattle 
Chapter overviews 
Chapter 2 is the literature review, which focuses on available diagnostic assays for BTB in animals 
and the effect of TSTs on these assays. Chapter 3 describes the chosen methodology for the 
studies and includes detailed protocols for all assay procedures. Chapter 4 sets out the results; 
Chapter 5 discusses the results in detail and draws conclusions and future recommendations. 
Chapters 3, 4 and 5 contain three separate studies; the first study investigates the temporal 
changes in immunological responses in naturally M. bovis-infected African buffaloes. The second 
study describes the temporal changes in antigen-induced cytokine release following the SICT in 
cattle, and the third study investigates the changes in antigen-induced cytokine release following 
the SICCT in African buffaloes. Chapter 6 presents the overall conclusion.   
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Chapter 2: Literature review 
The influence of tuberculin skin tests on in vitro and in vivo immunological 
responses to bovine TB 
2.1 Introduction  
Tuberculosis is a major global infectious disease that is caused by organisms of the 
Mycobacterium tuberculosis complex. Mycobacterium tuberculosis and Mycobacterium bovis are 
the most important causative agents of TB in, respectively, humans and a wide range of animal 
species, including African buffaloes, lions, warthogs, cattle, kudu, etc. (Michel et al., 2006; Palmer 
et al., 2006). Tuberculosis is regarded as one of the leading causes of death in humans worldwide, 
resulting in 1.5 million human deaths and 9.6 million new cases in 2014 (“WHO | Global 
tuberculosis report 2015,” n.d.). In cattle, approximately 50 million individuals were infected 
worldwide with M. bovis in 2006 (Buddle et al., 2009). 
Bovine tuberculosis, which is caused by M. bovis, has an impact on livestock and wildlife through 
decreased productivity, including reduced fecundity and body condition and loss of animals due to 
natural death or culling as part of the test-and-cull strategy that is implemented in many countries 
(Jolles et al., 2005; Michel et al., 2010, 2006). Also, carcasses and other animal products with TB 
lesions are condemned at slaughter. All of these issues lead to major economic losses (Michel et 
al., 2006; Thom et al., 2006). Bovine TB is a zoonotic disease that can spread between wildlife, 
livestock and humans. It therefore presents a major threat of infection between multiple species 
and is a significant public health concern (Coad et al., 2010; Michel et al., 2010). Translocation of 
animals both nationally and internationally are problematic in areas with a high BTB burden, since 
movement of animals presents a major risk factor in the spread of M. bovis into BTB free areas 
(Michel et al., 2010, 2006; Parsons et al., 2011). Due to restricted translocation of animals between 
parks, conservation programs may be negatively impacted by the limited exchange of genetic 
material (Michel et al., 2006). Furthermore, detection of BTB on a farm or reserve will result in it 
being placed under quarantine, with animal sales and movement of animal products terminated, 
which may further influence farm revenues, and tourism and hunting in the case of wildlife (Hlokwe 
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et al., 2016; Michel et al., 2006). Quarantine and movement restrictions result in a decline in 
international and national animal and animal product trade (Michel et al., 2010, 2006; Parsons et 
al., 2011).  
Buffaloes play an important role in ecotourism since they form part of the iconic “Big Five” animals 
of Africa and are also often used for farming purposes (Michel and Bengis, 2012). Furthermore, 
these animals are of high ecological value, since they are bulk grazers that occur in large herds 
and therefore open up habitats which benefits other species such as smaller animals, elective 
feeders and short grass feeders. Buffaloes are also a food source for many predators, such as 
lions (Michel et al., 2010; Michel and Bengis, 2012). Moreover, buffaloes are maintenance hosts of 
BTB, which allows the persistence of the disease within an area without a source of reinfection. 
Infected animals can live for years with reasonably good health, but be potential sources of M. 
bovis contamination to other species (De Vos et al., 2001; Michel et al., 2006). Buffaloes make 
especially good maintenance hosts due to their social behaviour and gregarious nature. Therefore, 
total eradication of BTB is extremely difficult in an area in which the infection is maintained by 
these hosts (De Vos et al., 2001; Palmer et al., 2012). 
Effective disease management strategies are crucial to prevent the spread of BTB within a herd or 
to other animals, especially with translocation of livestock or wild animals (Buddle et al., 2009; 
Karesh et al., 2016). Management of maintenance hosts is of particular importance, since lack of 
effective control will result in indefinite persistence of infection and potential transmission to other 
species (Gormley et al., 2004; Hlokwe et al., 2016; Michel et al., 2006; Palmer et al., 2012). 
Accurate diagnosis of BTB is fundamental for disease management strategies to identify M. bovis-
infected animals at an early stage and remove them from the herd before becoming a source of 
infection (Gormley et al., 2006; Thom et al., 2006). Ante-mortem BTB diagnostic assays with high 
sensitivity, i.e. the probability of correctly identifying an animal that is truly infected, and specificity, 
i.e. the probability of correctly identifying an animal as truly uninfected, would therefore be ideal to 
detect infected animals before they shed M. bovis bacilli into the environment (Buddle et al., 2009; 
de la Rua-Domenech et al., 2006; Thom et al., 2006). Typically, assays with high sensitivity would 
be implemented in high BTB prevalence herds to accurately identify and remove BTB-positive 
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individuals. In herds where BTB probability is low, assays with high specificity are required to 
reduce the number of false-positive animals that are identified and removed (Buddle et al., 2009; 
de la Rua-Domenech et al., 2006). 
2.2 Currently available TB diagnostic tests  
Direct detection of mycobacterial organisms provides a definitive diagnosis of TB. Mycobacterial 
culture is currently regarded as the gold standard for M. bovis infection (de la Rua-Domenech et 
al., 2006; de Lisle et al., 2002), although it has some limitations, including imperfect sensitivity, 
prolonged culturing period, difficulty of culturing some mycobacterial species and the limited ability 
to differentiate between different mycobacterial species (de Lisle et al., 2002; Michel et al., 2010). 
Speciation by polymerase chain reaction (PCR) or other genetic procedures on culture isolates 
provide the opportunity to identify the mycobacteria of interest and perform epidemiological studies 
(Michel et al., 2010; Schiller et al., 2010). PCR can also be performed directly on homogenised 
tissues, bodily fluids (e.g. blood, urine, respiratory or gastric lavage samples), faeces and nasal 
swabs, without time-consuming bacterial culturing procedures. However, this requires more 
sophisticated laboratory equipment and may have poorer sensitivity and specificity due to various 
factors, including low number of bacilli present in samples and inefficient deoxyribonucleic acid 
(DNA) extraction (de la Rua-Domenech et al., 2006). Also, acid-fast staining, such as Ziehl-
Neelsen, can be done directly on smears taken from tuberculous lesions and examined by 
microscopy. This method is inexpensive and easy to perform, but lacks sensitivity due to low bacilli 
counts in the lesions, and specificity due to the presence of non-tuberculous mycobacteria (de 
Lisle et al., 2002). 
Ante-mortem immunodiagnostic assays have many advantages, such as greater specificity and 
sensitivity, ability to detect bacilli in low numbers, time-efficiency and allowing early detection of 
infection (14 days post-infection) (Gormley et al., 2006). Immunodiagnostic assays measure 
mycobacteria-specific immune response for diagnosis of infection. Cell-mediated immune (CMI) 
responses involve the differentiation and proliferation of naïve T-cells into active cells (effector 
cells) in response to specific antigens. CD4+ effector T-cells secrete cytokines, such as IFN-ɣ, 
which are proteins that play a key role in the regulation of the immune response, including the 
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activation of B-lymphocytes and macrophages (Janeway et al., 2001). The humoral immune 
response is mediated by antibodies that are produced by B-lymphocytes. Upon recognition of 
specific antigens, B-cells are activated and differentiate into plasma cells that can secrete specific 
antibodies with the aid of T-helper (Th) cells (Janeway et al., 2001). Since mycobacterial 
stimulation of antibody production appears to be antigen load-dependent, humoral responses are 
often observed only after development of disease, rather than in earlier stages of infection and 
increase substantially as disease progresses (Casal et al., 2014; de la Rua-Domenech et al., 2006; 
Janeway et al., 2001). 
Assays of humoral immunity detect antibody responses to mycobacterial antigens in serum and 
are typically more effective in detecting animals which are at advanced stages of infection or 
exposed to high levels of mycobacteria (de la Rua-Domenech et al., 2006; Palmer et al., 2006). 
However, in some species, such as elephants and warthogs, serological assays can detect 
infection without significant signs of disease (Greenwald et al., 2009; M. Miller, pers. comm.). 
Serological assays are less costly and easy to perform, but have relatively low sensitivity in cattle 
and some other species (Buddle et al., 2009; de la Rua-Domenech et al., 2006). Inclusion of M. 
bovis antigens, such as immunodominant MPB83, MPB70, culture filtrate protein 10 (CFP-10) and 
early secretory antigenic target 6 (ESAT-6), has increased the specificity, but not the sensitivity, of 
serological assays (de la Rua-Domenech et al., 2006). MPB70 and MPB83 are constitutively 
expressed in M. bovis, but are hardly detected in mycobacteria with a region of difference 2 (RD2) 
deletion, such as Bacille Calmette Guerin (BCG) (Lyashchenko et al., 2004). There are many 
serological assays available that make use of these immunodominant antigens. These include 
immunochromatographic dual-platform VetTB assays containing MBP83, ESAT-6 and CFP-10, 
multi-antigen print immunoassays using 12 antigens of the M. tuberculosis complex  (ESAT-6, 
CFP-10, bovine PPD, MPB70 and MPB83), IDEXX enzyme-linked immunosorbent assays 
(ELISAs) using MPB83 and MPB70 antigens, and an indirect ELISA using bovine PPD as capture 
antigen (Schiller et al., 2010; Waters et al., 2015). 
Diagnostic assays of CMI can detect animals at an early stage of infection and are more sensitive 
than assays of humoral immunity in livestock (de la Rua-Domenech et al., 2006). The most 
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commonly used CMI assay for BTB is the TST. It is based on the intradermal injection of PPD, 
which elicits a DTH response that is associated with the influx of sensitised T-cells and monocytes 
to the site of injection. Cytokines are released, which recruits more inflammatory cells 
(e.g.  neutrophils, macrophages, monocytes) to the area, and causes vasodilation and ultimately 
swelling in this area which peaks about 72 h after the PPD injection (Buddle et al., 2009; de la 
Rua-Domenech et al., 2006). There are various ways to perform a TST, including the single 
intradermal cervical skin test (SICT), caudal fold test (CFT) and the single intradermal comparative 
cervical skin test (SICCT). The SICT and the CFT involves the intradermal injection of bPPD in the 
mid-cervical region and in the caudal fold, respectively (Buddle et al., 2009; Coad et al., 2010; de 
la Rua-Domenech et al., 2006). The change in skin fold thickness (SFT) at the site of injection after 
72 h is measured with callipers and the area is examined for any cardinal signs of inflammation, 
i.e. heat, swelling, oedema and erythema. Cattle are regarded as test-positive if the increase in 
SFT is ≥ 4 mm (Buddle et al., 2009; Coad et al., 2010). The specificity of these tests are, however, 
reduced if the animals are exposed to non-tuberculous mycobacteria, such as bacteria from the M. 
avium complex, since exposure to these mycobacteria can result in a false-positive skin test result 
(Ryan et al., 2000). The SICCT involves the intradermal injection of both bPPD and avian PPD 
(aPPD) at two different sites in the mid-cervical region. The changes in SFT at each site are 
measured after 72 h and the differential response to aPPD and bPPD is determined (Buddle et al., 
2009; Coad et al., 2010). Buffaloes with a change in SFT ≥ 2 mm (Parsons et al., 2011) and cattle 
with a change ≥ 4 mm (Buddle et al., 2009) are regarded as test-positive. The inflammatory 
response to aPPD is compared to the response to bPPD to distinguish M. bovis infections from 
those due to environmental mycobacteria (Coad et al., 2010; Thom et al., 2006). Therefore, fewer 
false-positive animals will be detected by the SICCT compared to the SICT or CFT, increasing the 
specificity of this test. However, the SICCT may have a lower sensitivity than the other two TSTs 
that only use bPPD, since a large response to aPPD may mask a response to bPPD which would 
lead to an increase in false-negative animals (Buddle et al., 2009; Parsons et al., 2011; Ryan et al., 
2000). 
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One of the most commonly used in vitro immunodiagnostic assays of CMI is the IGRA, which is a 
sensitive and specific test for detection of TB in humans and livestock. These tests can detect M. 
bovis infection earlier following infection than the TST (Gormley et al., 2006). IGRA kits are 
commercially available, for example the Bovigam® ELISA (ThermoFisher Scientific) for cattle 
(Gormley et al., 2006; Palmer et al., 2006; Sinclair et al., 2016) and QuantiFERON Gold In-Tube 
(QFT, Qiagen) in humans (Katial et al., 2001; Britton et al., 2005). IGRAs in animals are based on 
the stimulation of sensitised T-lymphocytes in the blood of M. bovis-infected animals with BTB 
antigens, such as bPPD, aPPD, ESAT-6, CFP-10 and other antigens (Buddle et al., 2009). Upon 
recognition of the specific antigen, T-lymphocytes release IFN-ɣ, which results in the activation of 
macrophages that kill mycobacteria in vivo (Buddle et al., 2009). IFN-ɣ has been shown to be a 
sensitive biomarker of T-cell activation as it correlates well with the efficacy of immune responses 
(Chakera et al., 2011). Therefore, measurement of IFN-ɣ by ELISA in vitro is a good representation 
of in vivo immune responses, with high IFN-ɣ concentrations in antigen stimulated samples 
correlating well with M. bovis infection (Chakera et al., 2011). The assay is performed by 
measuring the differential release of cytokines in antigen–stimulated and unstimulated whole blood 
samples using a sandwich ELISA (Ryan et al., 2000; Whipple et al., 2001). 
Various mycobacterial-derived antigens are used for stimulation of blood samples as part of the 
IGRA procedure. Combinations of antigens have been used in the assay to increase sensitivity or 
specificity, depending on the application. These include PPDs, ESAT-6, CFP-10 and the 
commercially available Bovigam® PC-EC and PC-HP cocktails. Bovine PPD and aPPD are crude 
antigen preparations derived from heat-killed M. bovis and M. avium, respectively, which contain a 
variety of antigens (de la Rua-Domenech et al., 2006; Palmer et al., 2006). These PPDs are 
standardly used in the Bovigam® assay. The specificity, but not sensitivity, of the assays have 
been improved by utilising Bovigam® PC-HP and PC-EC antigenic cocktails, which are typically 
used in new generation IGRAs, for example Bovigam® 2G. In buffaloes, the sensitivity of the PPD 
assay is significantly greater than that of the highly specific PC-EC assay, but is not significantly 
greater than that of the PC-HP assay (W. Goosen, pers. comm.). PC-EC and PC-HP are derived 
from the M. bovis proteins, ESAT-6 and CFP-10, with PC-HP also utilising peptides derived from 
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Rv3615 and three additional, proprietary, mycobacterial antigens (Goosen et al., 2014). Genes 
encoding ESAT-6 and CFP-10 are located in the genetic RD1, which are deleted from Bacille 
Calmette Guerin (BCG) and most non-tuberculous mycobacteria, including M. avium, thereby 
minimising cross-reactions with environmental mycobacteria and improving specificity (Buddle et 
al., 2009; Pollock and Andersen, 1997a; Thom et al., 2004). The QFT assay utilises ESAT-6, CFP-
10 and TB7.7, which improve the specificity of the IGRA (Parsons et al., 2011). However, the QFT 
and Bovigam® PC-EC assays are less sensitive than the Bovigam® PC-HP assay (Goosen et al., 
2015).  
Even though these antigen combinations improve the sensitivity and specificity of the IGRA, the 
assay remains suboptimal for the detection of M. bovis infection in wild animals. Another 
biomarker, IP-10, has recently been identified for use in wild animals and is showing great potential 
in detection of TB in both humans (Ruhwald et al., 2009), African buffaloes (Goosen et al., 2014) 
and cattle (Parsons et al., 2016). IP-10 is induced by IFN-ɣ and produced by monocytes to 
primarily facilitate attraction of immunocompetent cells to sites of inflammation (Chakera et al., 
2011; Chegou et al., 2014; Ruhwald et al., 2009). IP-10 is released at significantly greater 
concentrations in stimulated blood samples than IFN-ɣ; approximately 100-fold higher than IFN-ɣ 
(Chegou et al., 2014; Goosen et al., 2015; Ruhwald et al., 2009). Therefore, if T-lymphocyte 
numbers are low in a sample, IFN-ɣ may be produced at levels below the threshold of detection. 
However, there may be sufficient IFN-ɣ to activate IP-10 production that can be detected by ELISA 
(Goosen et al., 2015). The sensitivity and specificity of IP-10 assays are comparable with the 
IGRA, although there is evidence that measurement of IP-10 may enhance sensitivity in humans, 
cattle and buffaloes (Chegou et al., 2014; Goosen et al., 2014; Parsons et al., 2016).  
Cytokine release assays are often performed at the same time (parallel testing) or shortly after 
(serial testing) performing a TST. Parallel testing involves the simultaneous application of both 
tests, and animals are considered test-positive if they are positive on either assay (Coad et al., 
2007; Ryan et al., 2006; Whipple et al., 2001). It may also involve testing only TST-negative 
animals on CRAs (Sinclair et al., 2016). Using the TST and CRA in parallel improves the overall 
sensitivity through identification of additional false-negative animals on one of the tests. Parallel 
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testing is therefore useful in herds with high BTB prevalence as this would allow removal of all 
possible M. bovis-positive animals (Gormley et al., 2006; Sinclair et al., 2016). Assays with high 
sensitivity are inadequate for BTB diagnosis in herds with low BTB probability, as they will identify 
inappropriately large numbers of false-positive animals in the herd which would cause unnecessary 
economic losses to the farmer (Gormley et al., 2006). Therefore, serial testing is more appropriate 
for herds with low BTB probability, since specificity, at the expense of sensitivity, is greatly 
improved, thereby reducing the identification of false-positive animals in the herd. Serial testing 
involves testing TST-positive animals with the CRA. Animals are regarded test-positive if they are 
positive on both tests (Coad et al., 2007; Gormley et al., 2006; Ryan et al., 2006; Sinclair et al., 
2016; Whipple et al., 2001). 
However, even though CRAs and TSTs are often used in combination to improve sensitivity or 
specificity, many studies have shown that the performance of CRAs may be influenced by the 
intradermal injection of PPD during the TST (Coad et al., 2010; Gormley et al., 2004; Whipple et 
al., 2001).  
Many other factors may also influence the performance of diagnostic assays in animals, especially 
when testing wild animals. These include the use of opioids as immobilisation drugs, which may 
result in inhibition of immune responses (Garcia et al., 2012; Sacerdote, 2006), exposure to 
environmental mycobacteria, time delay between blood collection and processing (Gormley et al., 
2004) and stress caused by capture and captivity during the testing period. Stress may result in 
increased levels of glucocorticoids, such as cortisol, which may result in immune suppression and 
therefore significantly reduced cytokine release up to 18 weeks after capture (Cross et al., 1999; 
Franceschini et al., 2008; Gormley et al., 2006; Griffin and Thomson, 1998).  
2.3 Effect of TST on the diagnostic performance of TB immunoassays 
2.3.1 Effect of multiple TSTs on sensitivity and specificity of the TST 
In many BTB testing programs, TSTs are performed on cattle followed by another TST as a 
confirmatory test (Coad et al., 2010). Also, in situations where BTB is identified or suspected in an 
area, TSTs are often performed at short intervals, approximately 60 days apart, to identify and 
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remove all test-positive animals as quickly and effectively as possible (Coad et al., 2010). 
However, repeated skin testing that is performed at short intervals may result in a reduction in the 
ability of an animal to respond to tuberculin, i.e. desensitisation or suppression of immune 
responses, which may lead to increased numbers of false-negative test results in the herd (Coad et 
al., 2010; de la Rua-Domenech et al., 2006; Palmer et al., 2006; Thom et al., 2004). This effect 
was also clearly seen in a cattle study by Ameni et al. (2007) in which SICCT-responders declined 
from 14% to 1% in a 1 year period after three consecutive SICCTs were performed every three 
months. Desensitisation was also reported in rhesus monkeys after TSTs were performed every 
two weeks for 14 weeks (Min et al., 2014). It has been shown that the suppression of the TST 
response may occur as soon as seven days after the initial TST and may remain suppressed for 
50 to 60 days (Doherty et al., 1995; Palmer et al., 2006). Therefore, a minimum of 60 days 
between TSTs is recommended for reactivity to the TST to return to normal (Buddle et al., 2009; 
Coad et al., 2010; Ryan et al., 2000; Thom et al., 2006). In the USA, TSTs may only be repeated 
within 10 days or after 90 days of the initial TST. However, Coad et al. (2010) found that even 
when SICCTs were performed at 60 day intervals, desensitisation to tuberculin was observed, 
particularly by the third consecutive TST. Therefore, it seems that 60 days between repeated TSTs 
may not be sufficient (Coad et al., 2010). Interestingly, a significant decrease in the skin test 
response was only seen in response to bPPD, whereas the response to aPPD was not affected by 
repeated SICCTs (Coad et al., 2010).  
Studies have demonstrated that there are multiple cytokines that may be involved in the 
desensitisation effect. These include interleukin (IL)-10, IL-6 and IL-1β. It has been shown that 
injection of PPD for the TST can lead to elevated levels of IL-10 (Coad et al., 2010); single and 
repeated SICCTs have resulted in significant increases in IL-10 production (Coad et al., 2010; 
Thom et al., 2006). IL-10 can inhibit DTH responses and therefore increased levels of this cytokine 
may result in desensitisation (Coad et al., 2010; Schwarz et al., 1994; Thom et al., 2006). 
However, increased IL-10 production post-SICCT was not seen in M. bovis-uninfected cattle (Coad 
et al., 2010). Furthermore, Thom et al. (2006) found that production of IL-6, a pro-inflammatory 
cytokine, decreased following repeated SICCTs which would also suppress a TST response. IL-1β 
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is a mediator of the inflammatory response that is required for T-cell activation and the DTH 
response (Coad et al., 2010). Cattle that had single or multiple SICCTs showed a significant 
decrease in IL-1β production post-SICCT which would result in a decrease in the DTH response 
(Coad et al., 2010; Thom et al., 2006).  
Animals may also develop a hypersensitivity response to tuberculin due to repeated skin testing. 
Hypersensitivity, or sensitisation to tuberculin, in cattle has been reported as early as 1891 
(Monaghan et al., 1994) and shown to occur between three and six weeks after the first TST 
(Palmer et al., 2006). Sensitisation results in an increase in false-positive animals on TST (de la 
Rua-Domenech et al., 2006; Palmer et al., 2006); this effect is often seen in herds with low BTB 
prevalence (Monaghan et al., 1994).  
Interestingly, TST results of M. bovis-uninfected cattle have not been shown to be affected by 
repeated skin testing (Thom et al., 2004, 2006).  
2.3.2 Effect of TSTs on cytokine release assays 
Cytokine release assays are often used in parallel or series with TSTs to improve diagnostic 
performance. However, studies have shown that performing a CRA shortly after the TST may 
influence the results of the CRA. There have been many conflicting findings regarding the influence 
of TSTs on CRAs. This may be due to various factors, including the type of TST that was 
performed, naturally vs. experimentally infected animals, antigens used for blood stimulation, 
cytokines measured, and time points at which CRAs were performed (Palmer et al., 2006).  
Rothel et al. (1992) and Wood and Rothel (1994) reported a decline in IFN-ɣ release in response to 
PPD up to seven days post-CFT in experimentally infected cattle. This was followed by a gradual 
increase in IFN-ɣ release, which remained elevated for 59 days after the CFT. In contrast, other 
studies reported a boost in IFN-ɣ release in response to PPD, ESAT-6 and CFP-10 between three 
and seven days post-CFT (Palmer et al., 2006) and in response to PPD between three and 28 
days post-CFT in experimentally infected cattle (Whipple et al., 2001). Similarly, an increase in 
IFN-ɣ release was seen shortly after the TST was performed in humans, which remained elevated 
four weeks post-TST (Vilaplana et al., 2008). However, ÓNualláin et al. (1997) found that the 
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SICCT caused a significant decrease in IFN-ɣ production in response to bPPD between one and 
28 days post-SICCT in naturally infected cattle, whereas Whelan et al. (2004) also reported a 
decline in IFN-ɣ in response to bPPD, aPPD, ESAT-6 and CFP-10 three days post-SICCT in 
experimentally infected cattle.  
Other studies have found that the TST had no effect on IFN-ɣ release, and therefore on the CRA 
outcome. No change in IFN-ɣ release in response to PPD in naturally infected cattle following a 
single SICCT or multiple repeated SICCTs has been reported, measured up to seven days 
(Doherty et al., 1995) or 65 days post-SICCT (Coad et al., 2010; Gormley et al., 2004). Another 
study reported a greater IFN-ɣ response at 3 days post-SICCT compared to pre-SICCT and 10 
days post-SICCT, but this was not statistically significant (Coad et al., 2007). No significant 
changes in IFN-ɣ release in naturally infected cattle was reported by Ryan et al. (2000) when 
measured between eight and 28 days post-CFT. Also, Thom et al. (2006) reported that the SICCT 
had no significant effect on the IGRA test outcome, but did cause a boost in IFN-ɣ production in 
response to aPPD, but not to bPPD, in experimentally M. bovis-infected cattle. Furthermore, it has 
been shown that the effect of the TST on subsequent IFN-ɣ release is not influenced by the 
number of repeated TSTs (Rangen et al., 2009).  
Of note, many studies found that the CFT, rather than the SICCT, caused a boosting of IFN-ɣ in 
CRAs (Coad et al., 2010; Gormley et al., 2006). Coad et al. (2010) directly compared the effect of 
the SICCT versus that of the CFT on IFN-ɣ response in cattle and showed that CFTs, but not the 
SICCT, caused a significant increase in IFN-ɣ in response to PPD at three days post-CFT which 
returned to pre-CFT levels by 10 days post-CFT (Coad et al., 2010). Interestingly, CRAs that used 
bPPD and aPPD for blood stimulation, showed that the boosting of IFN-ɣ in the comparative 
response to aPPD and bPPD was due to a significant increase in response to bPPD in M. bovis-
infected cattle only, since the IFN-ɣ response to aPPD was not affected by the CFT. However, 
Thom et al. (2006) found that the SICCT caused a greater boosting effect in aPPD compared to 
bPPD 1 week post-SICCT in infected cattle.  
Significant boosting of IFN-ɣ levels due to the injection of PPD for the TST was only seen in M. 
bovis-infected, but not in M. bovis-uninfected cattle, which suggests that the boosting effect may 
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actually enhance the sensitivity of the assay, since identification of M. bovis-positive animals could 
be improved without identifying more false-positive animals (Palmer et al., 2006). Moreover, IFN-ɣ 
release in response to ESAT-6 and CFP-10 was less affected by the TST than responses to PPD 
in M. bovis-uninfected cattle (Palmer et al., 2006).  
2.3.3 Effect of TSTs on serological assays 
It has been shown that TSTs may cause a boosting effect in antibody responses (Hanna et al., 
1992; Lyashchenko et al., 2004; Palmer et al., 2006; Thom et al., 2006). This was specifically 
observed in response to the immunodominant antigens, MPB83 and MPB70 and also to ESAT-6 
and bPPD in cattle (Lyashchenko et al., 2004; Palmer et al., 2006; Thom et al., 2006). MPB70 and 
MPB83 are major components of bPPD, which is intradermally injected for the TST and may 
stimulate a B-lymphocyte memory response which could explain the boosted antibody responses 
to these antigens (Lyashchenko et al., 2004; Miller et al., 2015). Furthermore, Thom et al. (2006) 
found that the expression of IL-4, cytokines that induce B-cells to proliferate and produce 
antibodies, increased following the SICCT, which would result in increased antibody responses. 
Increased antibody responses to MBP70 and MPB83 were seen as early as 2 weeks post-CFT in 
cattle, which decreased over the next 2 to 3 months (Waters et al., 2015). Furthermore, the CFT, 
followed by the SICCT 105 days later, resulted in a massive antibody boost by seven days post-
SICCT in M. bovis-infected cattle (Waters et al., 2015). However, increased antibody responses 
were only observed in response to MPB70 and MPB83, but not to ESAT-6 and CFP-10 (Waters et 
al., 2015).The boosting effect of TST in antibody responses has also been seen in wildlife species. 
Specifically, a significant increase in antibody levels were seen from the day when the TST was 
performed to 17 days post-TST in a TB-positive black rhinoceros (Miller et al., 2015). Interestingly, 
Thom et al. (2006) found that cattle recently infected with M. bovis were easier to detect, using 
serological assays, after SICCTs were performed. This was probably associated with the TST 
boosting their limited antibody responses (Casal et al., 2014; Thom et al., 2006). In M. bovis-
uninfected cattle, antibody levels, and therefore the test outcome, were not affected by PPD 
injection for the TST (Hanna et al., 1992; Palmer et al., 2006; Thom et al., 2004). For this reason, 
the TST could be used in conjunction with serological assays to identify M. bovis-infected cattle 
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more accurately without increasing false-positive animals (Palmer et al., 2006; Thom et al., 2004). 
Therefore, since newly infected animals can be accurately identified post-TST and uninfected 
animals are not affected by the TST, the sensitivity of the serological assay can be significantly 
improved without compromising the specificity by using the TST in parallel (Palmer et al., 2006; 
Thom et al., 2006). In fact, Casal et al. (2014) found that the sensitivity of the serological tests 
increased significantly by 15 days post-TST. Interestingly, a boost in antibody responses correlates 
with disease severity; therefore, cases with more progressive disease showed a greater antibody 
boost (de la Rua-Domenech et al., 2006; Lyashchenko et al., 2004). 
2.4 The influence of NTMs on TB tests 
Most animals are exposed to environmental bacteria, specifically those belonging to the M. avium 
complex, throughout their lives. However, many studies have shown that exposure to and/ or 
infection with environmental mycobacteria may compromise IGRAs and TSTs by leading to 
increased numbers of false-positive or false-negative animals in a herd (Hope et al., 2005). It has 
been shown that animals that are aPPD-positive generally have decreased responses to bPPD 
(Aranaz et al., 2006). In M. bovis infected herds, the presence of M. avium results in decreased 
sensitivity of IGRAs and TSTs, with failure to detect M. bovis positive animals, despite the 
presence of BTB lesions (Alvarez et al., 2009; Álvarez et al., 2008; Amadori et al., 2002; Hope et 
al., 2005).  
The type of diagnostic assay applied in a herd with M. avium exposure may strongly influence test 
outcome. For instance, assays that use both aPPD and bPPD, such as SICCT and IGRA, may not 
accurately identify TST-positive animals, since a high aPPD response would skew the comparative 
test result. However, when applying an assay that makes use of bPPD only, such as a SICT or 
IGRA, the number of false-positive animals may increase, since it is not possible to differentiate 
between a response to bPPD and aPPD (Alvarez et al., 2009; Álvarez et al., 2008).  
 
 




Diagnostic assays with high specificity and sensitivity are required for effective management and 
BTB control programs in livestock and wildlife. Combinations of assays, in series or in parallel, 
have significantly improved diagnostic performance by increasing sensitivity or specificity. Although 
TSTs are often used in combination with cytokine release assays, serological assays, or a second 
TST, many studies have shown that TSTs can influence the outcome of the diagnostic assays in 
cattle. Further studies are required to study this effect in wildlife. Moreover, care must be taken 
when analysing results using multiple assays, especially in herds with high environmental 
mycobacterial exposure. 
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Chapter 3: Materials and methods 
3.1 Animals and sample processing  
3.1.1 Kinetics of immunological responses in naturally M. bovis-infected African 
buffaloes 
Between May 2015 and May 2016, African buffaloes (n = 18) were captured every 2 to 3 months 
for a total of 6 captures from a camp (approximately 9 hectare) at Satara, Kruger National Park, 
South Africa. Buffaloes were chemically immobilised as previously described (Parsons et al., 2011) 
and whole blood was collected by venipuncture of the jugular vein into heparinised blood tubes and 
serum tubes. On each sampling occasion, animals were tested using QFT and Bovigam® PPD 
ELISAs, as described below. However, due to logistical challenges, not all animals could be 
reliably captured at each time point.  Buffaloes were divided into groups according to their 
Bovigam® result and were included in the present study if they were Bovigam®-positive on two 
consecutive captures. Group 1 consisted of chronically Bovigam®-positive animals (n = 5) that 
were tested for the full study period; group 2 consisted of newly converted Bovigam®-positive 
animals (n = 5) that were included in the study from capture 4 – 6. Additionally, group 3 consisted 
of Bovigam®-negative animals (n = 8) that were kept in the same camp as the animals from 
groups 1 and 2 and were tested sporadically at different captures. 
3.1.2 Temporal changes in antigen-induced cytokine release in cattle 
Holstein cattle were sourced from a dairy farm in the Western Cape, South Africa, which has been 
under BTB quarantine for approximately 10 years. During this time, the SICT, as described below, 
was initially performed every 3 to 4 months. However, since no macroscopic lesions were found 
and no animals were M. bovis culture positive, the SICT was performed annually during the last 
few years. The study utilised two cohorts of cattle in the same herd from which heparinised whole 
blood was collected by venipuncture of the coccygeal vein. Group 1 consisted of 29 SICT-positive 
animals that were sampled 6 days and 41 days post-SICT and group 2 included 16 SICT-positive 
and 17 SICT-negative animals that were sampled at seven, 21 and 78 days post-SICT. These time 
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points were opportunistic samples determined by the availability of the cattle and veterinarian. 
Additionally, animals in group 2 were tested using the SICCT, as described below, at the time of 
blood collection 78 days post-SICT, prior to the TST. On each sampling occasion, animals were 
tested using the Bovigam® PPD ELISA and QFT assays, as described below.  
Animals from group 1 were slaughtered at circa 70 days post-SICT at a commercial abattoir and 
inspected for evidence of BTB lesions. Tissue samples were collected for mycobacterial culture, as 
described below.  
3.1.3 Changes in antigen-induced cytokine release in African buffaloes following 
the SICCT 
In July 2015, 286 African buffaloes were captured as part of an annual BTB control program in the 
Hluhluwe-iMfolozi Park (HiP), KwaZulu-Natal, South Africa, and held in temporary bomas before 
being chemically immobilised as previously described (Parsons et al., 2011). Whole blood was 
collected from each animal into heparinised blood tubes and serum tubes (BD Pharmingen, New 
Jersey, USA) by venipuncture of the jugular vein, and SICCTs were performed at this time (pre-
SICCT). Bovigam® PPD, PC-EC and PC-HP ELISAs were performed to measure IFN-ɣ and IP-10 
levels for each animal, as described below. All animals that tested positive to any Bovigam® 
ELISA (group 1; n = 55), a cohort of animals that were Bovigam® and SICCT-negative (group 2; n 
= 21) and animals that were SICCT-positive, but Bovigam®-negative (group 3; n = 5), were 
immobilised (as before) three days after the SICCT was performed (post-SICCT). The number of 
animals tested on each assay was subjected to the availability of stimulated blood for each animal. 
Blood was collected, as above, and the Bovigam® ELISAs were repeated for these animals. All 
Bovigam® and SICCT-positive animals were sacrificed and post-mortem examinations and 
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3.2 Ethical approval 
Ethical approval was obtained for the various studies from the University of Stellenbosch Animal 
Ethics committee. The ethics reference numbers were SU-ACUM13-00016 and SU-ACUD15-
00111. Also, Section 20 approvals for the Satara buffalo study and Hluhluwe-iMfolozi buffalo study 
were granted by the Department of Agriculture, Forestry and Fisheries, South Africa. 
3.3 Tuberculin skin tests 
3.3.1 Single intradermal cervical skin test 
Following measurement of the SFT at the site of injection, 0.1 ml bPPD (WDT, Hoyerhagen, 
Germany; 30 000 IU/ml) was intradermally injected in the neck. Three days hereafter, the SFT was 
measured again and examined for evidence of inflammation, including redness, oedema, necrosis 
and heat. Cattle were regarded as SICT-positive if the SFT showed an increase of more than 4 
mm (Buddle et al., 2009).  
3.3.2 Single intradermal comparative cervical skin test 
Single intradermal comparative cervical skin tests were performed by injecting 0.1 ml bPPD and 
0.1 ml aPPD (WDT) into the skin on the left and right side of the neck, respectively, following the 
measurement of the SFT at the sites of injection. After three days, the SFT was measured and the 
area examined for evidence of inflammation, as above. Buffaloes were considered SICCT-positive 
if the increase in skin fold thickness  at the bPPD site of injection was 2 mm more than that at the 
aPPD injection site (Parsons et al., 2011); whereas for the cattle the difference was more than 4 
mm to be regarded as SICCT-positive (Buddle et al., 2009). 
3.4 Cytokine release assays 
3.4.1 Bovigam® ELISA 
For all animals, aliquots of whole blood (250 µl) were incubated with 25 µl phosphate buffered 
saline (PBS); 25 µl bPPD, prepared according to the manufacturer’s instructions; 25 µl aPPD (both 
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Prionics, Schlieren, Switzerland), similarly prepared; and 25 µl pokeweed mitogen (PWM; Sigma-
Aldrich, St. Louis, Missouri, United States) solution in PBS (final concentration 5 µg/ml), 
respectively. In addition, for the HiP buffaloes, 250 µl whole blood aliquots were incubated with 25 
µl PC-HP peptide solution and 25 µl PC-EC peptide solution (both Prionics), respectively. 
Following incubation at 37˚C for 20 h, plasma was harvested and stored at -80˚C. In all studies, 
blood processing was conducted within six hours after sample collection.  IFN-ɣ release in the 
plasma samples was determined using the Bovigam® ELISA kit (Prionics) as follows. Equal 
volumes of plasma diluent buffer and plasma (50 µl each) were incubated in wells of pre-coated 
96-well microplates for 1h at room temperature (RT). All subsequent steps were also performed at 
RT. Positive and negative controls were added to appropriate wells in duplicate. Plates were 
washed by hand 5 times with wash buffer and 100 µl of horseradish peroxidase (HRP)-labelled 
anti-bovine IFN-ɣ in conjugate diluent buffer (1:100) was added to all wells. After 1 h incubation, 
plates were washed as before. A chromogen solution containing tetramethylbenzidine (TMB) in 
enzyme substrate buffer (1:100) was added to all wells (100 µl/ well) and incubated for 30 min in 
the dark. Thereafter 50 µl/ well of enzyme stopping solution (0.5 M H2SO4) was added to stop the 
colour reaction and the absorbance of each sample was read at 450 and 630 nm using a LT-4000 
Microplate Reader (Labtech, Uckfield, UK). For the assay to be valid, the mean absorbance 
(optical density; OD) of the negative controls must be < 0.13 and that of the positive control > 0.7. 
Also, the differential OD value between the response to PWM and Nil (ODPWM-Nil) must be ≥ 0.5.  
For each animal, the OD values measured in samples co-incubated with aPPD (ODaPPD) and PBS 
(ODNil) were subtracted, respectively, from samples stimulated with bPPD (ODbPPD). An animal was 
regarded as PPD positive if ODbPPD - ODNil ≥ 0.1 and ODbPPD - ODaPPD ≥ 0.1 and PPD negative if 
ODbPPD - ODNil < 0.1, or ODbPPD - ODaPPD < 0.1. Moreover, ODNil was subtracted from OD values 
from samples co-incubated with PC-HP (ODPC-HP) and PC-EC (ODPC-EC), respectively. Animals 
were regarded PC-HP-positive if ODPC-HP - ODNil ≥ 0.1 and PC-EC-positive if ODPC-EC – ODNil ≥ 0.1, 
and those with OD differential values < 0.1 were test negative. 
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3.4.2 QuantiFERON® -TB Gold In-Tube assay 
For all cattle and the Satara buffaloes, 1 ml heparinised whole blood was transferred to 
QuantiFERON® -TB Gold In-Tube (QFT) assay blood collection tubes (Qiagen, Venlo, Limburg, 
Netherlands). These included a Nil tube containing saline and a TB antigen tube containing a 
peptide cocktail simulating ESAT-6, CFP-10 and TB 7.7. Furthermore, aliquots of whole blood (250 
µl) were incubated with 25 µl PWM (final concentration: 5µg/ml) to serve as a positive control for 
each sample. The tubes were shaken vigorously, incubated for 20 h at 37˚C and centrifuged at 
3000 x g for 10 min after which the plasma fraction was harvested and stored at -80˚C. In all 
studies, blood processing was conducted within six hours after sample collection. The IFN-ɣ and 
IP-10 concentrations were determined using a bovine IFN-ɣ ELISA (Mabtech, AB, Nacka Strand, 
Sweden) and a bovine IP-10 ELISA (Kingfisher Biotech Inc., St. Paul, MN, USA), respectively, as 
described below. Animals were regarded QFT-positive if the IFN-ɣ concentration in the TB antigen 
stimulated sample, i.e. [QFTTB] minus that in the Nil sample, i.e. [QFTNil], was equal to or greater 
than 66 pg/ml (Parsons et al., 2011). For the IP-10 ELISA, an animal was regarded as test-positive 
if the IP-10 concentration in the TB antigen stimulated sample minus that in the Nil sample was 
equal to or greater than 1486 pg/ml (Goosen et al., 2015). 
3.4.3 Mabtech IFN-ɣ ELISA 
The IFN-ɣ concentration in selected plasma samples was determined as follows. Anti-bovine IFN-ɣ 
capture antibody (Kit 3119-1H-20; Mabtech) in PBS (2 ug/ml) was used to coat wells of 96-well 
MaxiSorp polystyrene ELISA plates (Thermo Fisher Scientific, Massachusetts, USA) which were 
incubated at 4˚C overnight. All subsequent steps were performed at RT. Plates were washed by 
hand with wash buffer (WB) consisting of 0.05% Tween-20 (Sigma-Aldrich, Missouri, USA) in PBS 
and all wells were blocked with 200 µl blocking buffer comprising 0.1% bovine serum albumin 
(Roche, Basel, Switzerland) in WB (BB-BSA). After 1 h incubation, plates were washed again and 
50 µl of selected plasma samples with 50 µl BB-BSA were added to individual wells, in duplicate. A 
dilution series of bovine recombinant IFN-ɣ protein (Mabtech), ranging from 0 – 1000 pg/ml was 
added to individual wells, in duplicate, and plates were incubated for 2 h. Plates were then washed 
and incubated for 1 h with a 0.25 µg/ml solution of biotinylated anti-bovine IFN-ɣ antibody in BB-
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BSA. After washing, plates were incubated for an additional 1 h with a 1:1000 solution of 
streptavidin-HRP (Mabtech) in BB-BSA. After a final wash step, plates were incubated for 20 min 
with TMB substrate solution (BD Pharmingen, New Jersey, USA) after which sulphuric acid (2M; 
50 µl/well) was added to stop the colour reaction. The optical density (OD) of each well was 
measured at 450 nm and 630 nm. The OD630 was subtracted from OD450 and the IFN-ɣ 
concentration for each sample was derived from the standard curve using GraphPad Prism 5 
software (GraphPad Software, Inc. La Jolla, USA).  
3.4.4 IP-10 ELISA 
The IP-10 concentration in selected plasma samples was determined using a protocol similar to 
the IFN-ɣ ELISA with the following differences. A 0.5 µg/ml solution of anti-bovine IP-10 capture 
antibody (catalogue no. PB0385B-100; Kingfisher Biotech Inc., St. Paul, MN, USA) in PBS was 
used to coat the wells of 96-well plates. After the blocking step, each well was incubated with 25 µl 
plasma sample and 75 µl BB-BSA and a dilution series of recombinant bovine IP-10 protein (100 
µl/well; catalogue no. RP0079B-005; Kingfisher), ranging from 0 - 5000 pg/ml. Plates were then 
incubated with a 0.2 µg/ml solution of biotinylated anti-bovine IP-10 antibody (catalogue no. 
PBB0393B-050; Kingfisher) in BB-BSA and thereafter with streptavidin-HRP (R&D systems, 
Minnesota, USA) diluted 1:200 in BB-BSA. Finally, plates were incubated with TMB substrate 
solution after which sulphuric acid (2M; 50 µl/well) was added to stop the colour reaction. The OD 
of each well was measured as before and the IP-10 concentration in each well was derived from 
the standard curve as above.  
3.5 Serological assays 
Serological assays were performed with the Satara buffalo serum samples. 96-well MaxiSorp 
polystyrene ELISA plates (Thermo Fisher Scientific, Massachusetts, USA) were coated with 100 µl 
of a 10 µg/ml bPPD solution (Prionics) in 0.05 M carbonate-bicarbonate buffer (pH 9.6; Sigma 
Aldrich). For every well coated with antigen, a control well was blocked with blocking buffer which 
consisted of 20% fat free milk in PBS and 0.05% Tween-20 (BB-FFM). Plates were incubated for 1 
h at 37˚C. All subsequent steps were performed at RT. Plates were washed 5 times by hand with 
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WB and all wells were blocked with a 200 µl volume BB-FFM for 1 h. Then, plates were washed as 
above and serum aliquots from each animal were diluted 1:200 in BB-FFM and added to 
appropriate test and control wells. After a 1 h incubation period, plates were washed and 100 
µl/well of HRP-conjugated recombinant protein A/G (Thermo Scientific, MA, USA) diluted 1: 20 000 
in PBS was added to the wells and incubated for 1 h. After a final wash step, plates were incubated 
15 min in the dark with TMB substrate solution, after which sulphuric acid (2M; 50 µl/well) was 
added to stop the colour reaction. The OD of each well was measured at 450 nm and 630 nm and 
an assay result for all animals was calculated as the mean OD450-630 value of the PPD-coated wells 
minus that of the no-antigen control wells (Δ OD).  
3.6 Cortisol ELISA 
For the HiP buffaloes, blood cortisol levels were measured in pre- and post-SICCT serum samples 
using a commercial competitive cortisol ELISA (Kit no. ab108665, Abcam, Cambridge, UK) to 
determine whether stress associated with capture changed between the two sampling time points, 
which may ultimately influence the cytokine assay results. Serum samples, ready-to-use standards 
(0, 10, 50, 150, 500 ng/ml) and negative controls (20 µl each), that were included in the ELISA kit, 
were added in duplicate to their respective wells in an anti-cortisol IgG coated 96-well microplate. 
Cortisol-HRP conjugate (200 µl/well) was added to all wells except to the negative control wells. 
After 1 h incubation at 37˚C, the plates were washed 3 times by hand with a wash buffer and 100 
µl TMB substrate solution was added to all wells. Plates were incubated for 15 min in the dark and 
100 µl stop solution was added. The OD of all wells was measured at 450 nm. The mean OD value 
of the negative control was subtracted from each point of the standard curve and each sample. 
The cortisol concentrations of each sample were determined from the standard curve as described 
above. The cortisol ELISA was only performed on 18 buffaloes that showed the greatest increase 
in IFN-ɣ release (group A) from pre- to post-SICCT and 18 animals that showed the greatest 
decrease in IFN-ɣ release (group B), as measured by Bovigam®. 
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3.7 Post-mortem examination, mycobacterial culture and speciation 
Animals were inspected for visible BTB lesions at post-mortem examination. Retropharyngeal, 
parotid, tracheobronchial, mediastinal, mesenteric, and mandibular lymph nodes and tonsils were 
collected from the HiP buffaloes. Retropharyngeal, tracheobronchial and mediastinal lymph nodes 
were collected from cattle. Tissues were sliced in 2-4 mm sections and examined for the presence 
of BTB lesions. Tissues with visible BTB lesions were cultured separately while tissues with no 
visible lesions were pooled for mycobacterial culture.   
Mycobacterial culture took place in a biosafety level 3 laboratory at Stellenbosch University, 
Tygerberg. Approximately 1cm3 of tissue in 2 ml PBS was homogenised for 15 min using metal 
beads (4 mm) in a bullet blender (Next Advance, Averill Park, NY, USA). Thereafter, tissue was 
decontaminated for 15 min with approximately 5 ml MycoPrepTM NACL-NaOH (Becton Dickinson, 
Franklin Lakes, NJ, USA) with frequent vortexing. Following the addition of approximately 10 ml 
PBS to neutralise the samples, the mixture was centrifuged at 3000 x g for 15 min. The 
supernatant was decanted and 500 µl of the pellet and 800 µl BBL MGIT PANTA antibiotic mixture 
was added to a Mycobacteria Growth Indicator Tube (MGIT), and incubated in a BACTEC MGITTM 
960 Mycobacterial Detection System (all Becton Dickinson) for 42 days. An aliquot from each 
culture positive sample was taken from the MGIT tubes and fixed on microscope slides, using 
serum albumin (NHLS, Johannesburg, SA) and heated for 2 h at 80˚C. Ziehl-Neelsen staining for 
acid-fast bacilli was performed as follows. Slides were flooded with carbol fuchsin (DMP, 
Johannesburg, SA), heated with a bunsen flame until steaming and left for 5 min. After repeating 
this step, slides were rinsed with water before being flooded with acid-alcohol (5%) for 2 min. The 
slides were rinsed again and covered with methylene blue (DMP) for 2 min. Thereafter, slides were 
rinsed and air dried overnight before being examined under a light microscope for acid-fast 
bacteria. Aliquots (200 µl) of ZN-positive culture samples were boiled for 30 min at 100˚C before 
being removed from the biosafety lab. Speciation polymerase chain reactions (PCRs) were 
conducted, as previously described (Warren et al., 2006), to determine whether the samples were 
M. bovis positive. In short, each 25 µl PCR reaction contained four primer sets containing forward, 
internal and reverse primers targeting RD1, RD4, RD9 and RD12. Furthermore, Q-buffer (5 µl), 
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DNA template (1 µl), 10x buffer (2.5 µl), MgCl2 (2 µl), deoxynucleotides (200 µM each) and 
HotStarTaq polymerase (0.125 µl) were added to the reaction. PCR cycling were initiated at 95˚C 
for 15 min, followed by 45 cycles at 94˚C for 1 min, 62˚C for 1 min and 72˚C for 1 min. Thereafter, 
samples were incubated at 72˚C for 10 min, after which gel electrophoresis was performed on the 
PCR amplification products at 100 V on a 1.5% agarose gel (Lonza, Montague Gardens, Cape 
Town, SA) in sodium tetraborate buffer (Sigma Aldrich). Ethidium bromide was used for gel 
staining and 2 µl 6x loading dye per 5 µl amplicon were used for sample loading. A GeneRuler 
100bp plus DNA ladder (Thermo Fisher Scientific) was added to the gel for band size 
determination. M. bovis positive samples had four bands of the following sizes: 108 base pairs 
(bp), 146 bp, 268 bp and 306 bp. 
3.8 Statistical analysis 
Data were tested for normality with the D'Agostino & Pearson omnibus normality test. Depending 
on which 2 groups were compared, a paired t-test or unpaired t-test was performed on data that 
were normally distributed. For data that were not assumed to follow a Gaussian distribution, the 
Mann Whitney U-test was performed on unpaired groups and the Wilcoxon signed rank test on 
those with paired observations. One-way ANOVAs were performed when comparing multiple 
groups. Data were analysed using GraphPad Prism 5 (GraphPad Software, Inc., La Jolla, USA). 
Data were presented as median and interquartile range, since these values are not affected by 
outliers and non-normal data and also provide a measure of variability for the tested herds.  
The diagnostic test evaluation calculator (Medcalc Software, Ostend, Belgium) was used to 
calculate the confidence intervals of the specificity of diagnostic tests and combinations thereof. 
McNemar’s test (GraphPad Software) were used to calculate the statistical difference between 
groups of paired observations, whereas Fishers’s exact test (GraphPad Software) was used to 
calculate the difference between independent groups. The Spearman Rank test was used to 
determine the correlation between assays and Cohen’s kappa was used to determine test 
agreement.  
  
Stellenbosch University  https://scholar.sun.ac.za
27 
 
Chapter 4: Results 
4.1 Kinetics of immunological responses in naturally M. bovis-infected 
African buffaloes 
4.1.1 Temporal changes in IP-10 and IFN-ɣ production 
IP-10 and IFN-ɣ concentrations in response to whole blood stimulation in QFT tubes [QFTTB – 
QFTNil] were measured by ELISA at various time points to investigate the temporal changes in 
these cytokines from 3 cohorts of buffaloes, i.e. group 1, chronically Bovigam® positive animals (n 
= 5); group 2, newly converted Bovigam®-positive animals with 2 consistent positive findings prior 
to inclusion in the study (n = 5); and group 3, Bovigam®-negative animals that originated from a 
high BTB prevalence area and were tested at random (n = 8). The median and interquartile range 
(IQR) of IFN-ɣ levels (pg/ml) from animals in groups 1 to 3 at all captures are shown in Table 1 and 
Figure 1 and the medians and IQR of IP-10 levels (pg/ml) are shown in Table 2 and Figure 1.  
 
Table 1: Medians and interquartile range (IQR) of IFN-ɣ release (pg/ml) in response to blood stimulation in 
QFT tubes [QFTTB – QFTNil]. 
 Group 1 Group 2 Group 3 
Captures Median IQR Median IQR Median IQR 
1 455.4 252.9 to 571.8  47.1 19.61 to 230.5 
2 590.6 260.8 to 952.2   
3 373 161.5 to 1387   
4 292.5 269.2 to 2081 6.3 0.001 to 239.5  
5 897.4 645.5 to 2299 0.9 -18.8 to 1.5 24.8 3.2 to 777.3 
6 637 168.8 to 1299 1.0 -0.8 to 7.6 10.4 -2.5 to 1715 
      
 Not done        
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Table 2: Medians and interquartile range (IQR) of IP-10 release (pg/ml) in response to blood stimulation in 
QFT tubes [QFTTB – QFTNil].  
 Group 1 Group 2 Group 3 
Captures Median IQR Median IQR Median IQR 
1 14967 12988 to 17293   7060 2479 to 10098 
2 8830 5482 to 16917     
3 7433 4002 to 12033     
4 13501 6282 to 14761 960.6 -111.6 to 1433   
5 12813 7748 to 16166 378.2 -121.4 to 1692 9296 1943 to 18057 
6 8025 7636 to 15319 54.34 -858.6 to 312.4 1922 -205.9 to 18901 
      
 Not done        
 
In group 1, there were no significant differences (p > 0.05; Kruskal-Wallis) in the median IP-10 or 
IFN-ɣ concentrations [QFTTB – QFTNil] between any of the 6 captures. All five buffaloes from Group 
1 (Table 3) were consistently test-positive at all 6 captures on both the QFT IFN-ɣ (Fig 1a) and 
QFT IP-10 assays (Fig 1d) which agreed with the positive Bovigam® results for all the animals 
from this group. There was perfect agreement between all assays (Cohen’s kappa = 1.0).  
In group 2, there were no significant differences (p > 0.05; Kruskal-Wallis) in the median IP-10 or 
IFN-ɣ concentrations [QFTTB – QFTNil] between captures 4, 5 or 6. Two of the 5 buffaloes were 
consistently negative at captures 4 – 6 on both the QFT IFN-ɣ (Fig 1b) and QFT IP-10 (Fig 1e) 
assays; a third animal (animal # C15) was negative at all 3 time points on the IFN-ɣ assay and at 2 
time points on the IP-10 assay (Table 3). Agreement between these 2 assays for group 2 was 
good (Cohen’s kappa = 0.6). However, the overall negative test outcome for group 2 was 
contradictory to the Bovigam® results, which were consistently positive from 2 captures before 
their inclusion in the study.  
In group 3, there were no significant differences (p > 0.05; Kruskal-Wallis) in the median IFN-ɣ (Fig 
1c) and IP-10 (Fig 1f) concentrations [QFTTB – QFTNil] between captures 1, 5 and 6, respectively. 
The M. bovis exposed buffaloes from group 3 were all Bovigam®-negative. However, the test 
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outcomes on the QFT IP-10 and QFT IFN-ɣ assays for the 8 animals in this group were 
inconsistent between captures and between individuals (Table 3). One of the group 3 buffaloes (# 
53, Table 3) was euthanised due to severe respiratory compromise and a post-mortem 
examination was performed. Lesions characteristic of BTB were found and the animal had severe 
aspiration pneumonia. This animal was consistently QFT IFN-ɣ and IP-10 positive. Agreement 
between the QFT IP-10 and QFT IFN-ɣ assays for group 3 was poor (Cohen’s kappa = 0.2).  
The median concentrations of, respectively, IP-10 and IFN-ɣ [QFTTB – QFTNil] were compared 
between the 3 groups. There was significantly greater (p ≤ 0.004; Mann-Whitney U test) IP-10 
release in group 1 compared to group 3 at capture 1, and group 1 compared to group 2 at captures 
4 and 5; no significant difference (p > 0.05; Kruskal-Wallis) was observed at capture 6 between 
any of the 3 groups. However, on the QFT IFN-ɣ assay, no significant differences (p > 0.05; Mann-
Whitney U test/ Kruskal-Wallis) in IFN-ɣ release were observed between any of the 3 groups at 
captures 1, 4, 5, or 6.  
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Table 3: Test outcome of the QFT IFN-ɣ and IP-10 assays for animals that were chronically Bovigam®-
positive (group 1), newly converted Bovigam®-positive (group 2) and Bovigam®-negative (group 3).  
   QFT IP-10 QFT IFN-ɣ 
   Capture Capture 







1 + + + + + + + + + + + + 
62 + + +  +  + + +  +  
38 + + +  + + + + +  + + 
57  + + + + +  + + + + + 







26    -      -   
63    +      +   
15    - - -    - - - 
27    - - -    - - - 







61 +      +      
50 +      -      
39 +    +  -    -  
48 -      -      
47 +    + - -    - - 
59 +      -      
53 +    + + +    + + 
52 +    - + +    - - 
      
 Not done; ʺ+ʺ, Test-positive; ʺ-ʺ, Test-negative    
 



































































































Figure 1: Temporal changes in IFN-ɣ (a, b, c) and IP-10 (d, e, f) concentrations (pg/ml) in response to whole 
blood incubated in QFT tubes [QFTTB – QFTNil] for animals from group 1 (a, d), i.e. chronically Bovigam®-
positive animals (n = 5), group 2 (b, e), i.e. newly converted Bovigam®-positive animals (n = 5) and group 3, 
Bovigam®-negative animals (n = 8). Diagnostic cut-off values are indicated as dotted lines. Medians and 





Stellenbosch University  https://scholar.sun.ac.za
32 
 
4.1.2 Temporal changes in the humoral response to M. bovis  
Antigen-specific antibody responses were measured by ELISA in the serum samples from the 3 
groups of buffaloes to determine if there were any changes over time. The median OD values of 
circulating antibodies of group 1 at captures 1 – 6, of group 2 at captures 4 – 6, and of group 3 at 
captures 1, 5 and 6 are shown in Table 4 and Figure 2. There were no significant differences (p > 
0.05, Kruskal-Wallis) in circulating antibody levels between captures in any of the 3 groups (Fig 2). 
Also, no significant differences (p > 0.05, Mann-Whitney U test/ Kruskal-Wallis) in antibody levels 
were observed between any of the 3 groups at captures 1, 4, 5 or 6.  
 
Table 4: Anti-PPD antibody levels (OD) in serum samples of animals from groups 1, 2 and 3 at 6 captures 
over a 1 year period.  
 Group 1 Group 2 Group 3 
Captures Median IQR Median IQR Median IQR 
1 0.5 0.4 to 0.6   0.4  0.3 to 0.8 
2 0.5 0.3 to 0.6     
3 0.5 0.3 to 0.54     
4 0.6  0.5 to 0.8 0.6 0.4 to 0.9   
5 0.3 0.3 to 0.5 0.4 0.2 to 0.6 0.5 0.4 to 0.6 
6 0.6 0.3 to 0.7 0.4 0.3 to 0.5 0.5  0.3 to 0.7 
      
 Not done        
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Figure 2: Anti-bPPD serum antibodies measured by ELISA (ΔOD, ODbPPD – ODNegative control) in buffaloes from 
a) group 1, b) group 2 and c) group 3 at specific time points. Medians with interquartile range are indicated 
by horizontal bars. 
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4.1.3 Temporal changes in host response to M. bovis in chronically infected 
buffaloes 
In order to assess potential changes in antigen-specific responses in buffaloes that were 
suspected to be chronically infected (group 1), cytokine and antibody responses were evaluated 
over a 1 year period. Figure 3 shows a comparison of the temporal changes in QFT IFN-ɣ and IP-
10 responses (pg/ml) and levels of anti-bovine PPD serum antibodies (Δ OD, ODbPPD – ODNegative 
control) for individual animals from group 1 over the study period. Although all 5 buffaloes from this 
group were positive on the QFT IFN-ɣ, QFT IP-10 and Bovigam® assays at all 6 captures, IP-10 
and IFN-ɣ concentrations fluctuated and no clear patterns of cytokine release over time or between 
animals were observed. Furthermore, antibody levels also fluctuated between captures and 
animals and no patterns of temporal changes were observed, although 2 animals showed a 
general increase (Fig 3d, e), 1 showed a decrease (Fig 3c) and 2 animals showed very little 
change over time (Fig 3a, b). Nevertheless, there was no significant correlation between any of the 
3 assays over time (p > 0.05; Spearman Rank Test). IP-10 concentrations were much higher than 
IFN-ɣ concentrations for all animals. 
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Figure 3: Antigen-specific immune responses over time. IFN-ɣ and IP-10 production [QFTTB – QFTNil] (pg/ml) 
and antibody levels to bPPD (Δ OD)  in individual animals, i.e. animals # 1 (a), # 62 (b), # 38 (c), # 57 (d) and 
# 20 (e), from group 1 at captures conducted over a 1 year period are indicated  
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4.2 Temporal changes in antigen-induced cytokine release in cattle 
4.2.1 Group 1: SICT-positive cattle 
4.2.1.1  Temporal changes in IFN-ɣ release in response to PPD (Bovigam®) post-SICT 
The Bovigam® assay was used to measure the antigen-specific IFN-ɣ release in whole blood from 
skin test positive cattle at 6 and 41 days post-SICT in response to bPPD and aPPD. At 6 days 
post-SICT, the median ODbPPD – ODNil was 2.7 (IQR: 2.4 to 2.8), that of ODaPPD – ODNil was 2.2 
(IQR: 1.2 to 2.6) and of ODbPPD – ODaPPD was 0.5 (IQR: 0.1 to 1.0). At 41 days post-SICT, the 
medians of ODbPPD – ODNil, ODaPPD – ODNil and ODbPPD – ODaPPD were 0.6 (IQR: 0.2 to 1.1), 0.2 
(IQR: 0.1 to 0.4) and 0.3 (IQR: 0.1 to 0.7), respectively (Figure 4). 
The release of IFN-ɣ in response to bPPD (ODbPPD – ODNil; Fig 4a) and aPPD (ODaPPD – ODNil; Fig 
4b) was significantly lower (p < 0.0001; Wilcoxon matched pairs test) at 41 days post-SICT than at 
6 days post-SICT. However, there was no significant difference (p = 0.14; Wilcoxon matched pairs 
test) in the differential response to these antigens (ODbPPD – ODaPPD) between the 6 and 41 day 
time points (Fig 4c). Twenty-four out of 29 (82.7%) animals were Bovigam®-positive at 6 days 
post-SICT, while 17 of the initial 24, and 5 additional animals (total 22; 75.9%) were positive at 41 
days post-SICT. There was no significant difference (p = 0.77; McNemar’s test) in the proportion of 
test-positive cattle at 6 days compared to 41 days post-SICT.  
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Figure 4: IFN-ɣ release at 6 and 41 days post-SICT in response to bPPD, aPPD and saline (Nil) in SICT-
positive cattle (n = 29). There was a significant decrease (p < 0.0001; Wilcoxon signed rank test) in IFN-ɣ 
release for a) ODbPPD – ODNil and b) ODaPPD – ODNil, but no significant difference between IFN-ɣ release at 6 
days and 41 days post-SICT for c) ODbPPD – ODaPPD. Horizontal bars represent medians.  
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4.2.1.2 Temporal changes in QFT test outcomes (IFN-ɣ and IP-10)  
IFN-ɣ and IP-10 concentrations (pg/ml) were measured at 6 and 41 days post-SICT in 29 SICT-
positive cattle after whole blood stimulation in QFT tubes. The median values for IFN-ɣ [QFTTB – 
QFTNil] at 6 and 41 days post-SICT (Fig 5a), were 25.7 pg/ml (IQR: 7.2 to 131.6 pg/ml) and 2.9 
pg/ml (IQR: -3.0 to 8.7 pg/ml), respectively. The median concentrations of IP-10 [QFTTB – QFTNil] 
(Fig 5b) were 2115 pg/ml (IQR: 345.7 to 6227 pg/ml) and 380.7 pg/ml (IQR: 28.8 to 1273 pg/ml) at 
6 and 41 days post-SICT, respectively. Using the Wilcoxon signed rank test, significant decreases 
in IFN-ɣ (p < 0.0001) and IP-10 (p = 0.0002) release were observed from 6 to 41 days post-SICT.  
Using the QFT IFN-ɣ assay, 10 of 29 (34.5%) cattle tested positive at 6 days post-SICT, whereas 
none tested positive at 41 days post-SICT (Fig 5a); 7 of the 10 animals that were QFT IFN-ɣ 
positive, were also Bovigam® positive at the 6 day time point. The difference in the proportion of 
QFT IFN-ɣ positive animals between 6 and 41 days was significant (0.0044; McNemar’s test). 
Seventeen out of 29 (58.6%) cattle tested positive with the QFT IP-10 assay at 6 days post-SICT 
whereas 4 of the initial 17 and 2 additional animals (total 6; 20.7%) were positive at 41 days post-
SICT (Fig 5b). The decrease in the proportion of IP-10 positive animals between 6 and 41 days 
was significant (p = 0.0098; McNemar’s test). The majority of IP-10 positive cattle (14/17 from day 
6 and 5/6 from day 41) were also Bovigam® positive. Moreover, 10 animals were positive at 6 
days post-SICT on both the QFT IP-10 and QFT IFN-ɣ assays, although none were positive on 
both tests at day 41. 
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Figure 5: Release of a) IFN-ɣ and b) IP-10 in whole blood from cattle (n = 29) stimulated in QFT tubes 
[QFTTB – QFTNil] at 6 and 41 days post-SICT. Horizontal bars represent medians. Diagnostic cut-off values 
are illustrated as dotted lines. Significant differences are indicated with a bracket and p-value. 
4.2.1.3 Post-mortem examination 
All 29 of the tested animals were sent to the abattoir. No visible lesions were observed at post-
mortem examination; head and thoracic lymph node samples collected for mycobacterial culture 
were M. bovis-culture negative.  
4.2.1.4 Diagnostic test specificity 
Specificities (
Truly negative
Truly negative + False positive
) were determined for the 3 assays, i.e. Bovigam®, QFT IFN-ɣ 
and QFT IP-10, and for combinations thereof (Table 5) using the 29 cattle which were all confirmed 
M. bovis-negative. The number of false positive plus truly negative animals was 29 (all cattle 
tested). In order to maximise specificity, animals were defined as test-negative if they were 
negative on 1 or more tests, and test-positive if they were positive on all tests used in the particular 
combination. At 6 days post-SICT, the combination of all 3 assays and the combination of 
Bovigam® and QFT IFN-ɣ assays had the highest specificity, but these were not significantly 
greater (p = 0.25) than the specificity of the QFT IFN-ɣ assay used alone or in combination with the 
QFT IP-10 assay. These tests, however, had a significantly greater (p < 0.05) specificity than all 
other assays or assay combinations. At 41 days post-SICT, the QFT IFN-ɣ assay used alone or in 
combination with any of the other assays had a significantly greater specificity than the QFT IP-10 
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(p = 0.04)  and Bovigam® (p = 0.0001) assays, but was not significantly greater than that for the 
combination of Bovigam® and QFT IP-10 assays. Moreover, apart from the Bovigam® assay, all 
assays and assay combinations showed significantly greater (p < 0.05) specificity at 41 days post-
SICT compared to 6 days post-SICT. Differences between diagnostic assays were calculated with 
McNemar’s test (GraphPad Software) and confidence intervals were determined with the 
diagnostic test evaluation calculator (Medcalc Software).  
 
Table 5: Specificity and 95% CI of diagnostic assays alone or in combination as calculated from group 1 M. 
bovis uninfected cattle (n = 29) at 6 days and 41 days post-SICT. 
 6 days post-SICT 41 days post-SICT 
 Diagnostic assay Specificity 95% CI Specificity 95% CI 
QFT IFN-ɣ 66% 46 - 82% 100% 88 - 100% 
QFT IP-10 41% 24 - 61% 79% 60 - 92% 
Bovigam® 17% 6 - 36% 24% 10 - 44% 
Bovigam® + QFT IP-10 52% 33 - 71% 83% 64 - 94% 
Bovigam® + QFT IFN-ɣ 76% 56 - 90% 100% 88 - 100% 
QFT IP-10 + QFT IFN-ɣ 66% 46 - 82% 100% 88 - 100% 
Bovigam® + QFT IP-10 + QFT IFN-ɣ 76% 56 - 90% 100% 88 - 100% 
CI; Confidence interval     
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4.2.2 Group 2: SICT-positive and SICT-negative cattle cohorts 
4.2.2.1 Temporal changes in IFN-ɣ release in response to PPD (Bovigam®) post-SICT 
A second cohort of animals from the same herd were included in the study to introduce a SICT-
negative subset of animals to examine the effect of the SICT on cytokine release in SICT-negative 
cattle. The Bovigam® assay was used to measure the IFN-ɣ levels in response to bPPD and aPPD 
in the SICT-positive and –negative cohorts at 7, 21 and 78 days post-SICT. The median values 
and IQR for ODbPPD – ODNil, ODaPPD – ODNil and ODbPPD – ODaPPD at 7, 21 and 78 days post-SICT 
of SICT-positive cattle (n = 16) are shown in Table 6 and of SICT-negative cattle (n = 17) are 
shown in Table 7.   
 
Table 6: Median OD values and interquartile range (IQR) of IFN-ɣ levels in response to bPPD, aPPD and the 
differential response to these antigens for SICT-positive animals at 7, 21 and 78 days post-SICT.  
 7 days post-SICT 21 days post-SICT 78 days post-SICT 
Condition Median IQR Median IQR Median IQR 
ODbPPD – ODNil 2.2 0.8 to 2.6 2.4 1.8 to 2.9 0.7 0.4 to 1.8 
ODaPPD – ODNil 1.4 0.6 to 2.3 1.6 1.0 to 2.7 0.5 0.3 to 1.2 
ODbPPD – ODaPPD 0.3 -0.03 to 0.9 0.2 -0.006 to 1.1 0.2 0.1 to 0.4 
 
Table 7: Median OD values and interquartile range (IQR) of IFN-ɣ levels in response to bPPD, aPPD and the 
differential response to these antigens for SICT-negative animals at 7, 21 and 78 days post-SICT. 
 7 days post-SICT 21 days post-SICT 78 days post-SICT 
Antigen Median IQR Median IQR Median IQR 
ODbPPD – ODNil 0.5 0.2 to 1.1 0.3 0.07 to 0.9 0.2 0.07 to 0.6 
ODaPPD – ODNil 0.5 0.2 to 1.4 0.3 0.08 to 0.9 0.2 0.06 to 0.7 
ODbPPD – ODaPPD 0.003 -0.1 to 0.13 0.004 -0.2 to 0.04 -0.007 -0.08 to 0.02 
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The release of IFN-ɣ in response to bPPD (Fig 6a and b) and in the differential response to bPPD 
and aPPD (Fig 6e and f), was significantly greater (p < 0.05; Mann Whitney U test) in SICT-positive 
cattle than in SICT-negative cattle at 7, 21 and 78 days post-SICT. However, IFN-ɣ release in 
response to aPPD only showed a significant difference (p = 0.003; Mann-Whitney U test) between 
the 2 groups at 21 days post-SICT, not at 7 or 78 days post-SICT (Fig 6c and d). Furthermore, 
using the Wilcoxon signed rank test, there was significantly lower IFN-ɣ release in response to 
bPPD at 78 days post-SICT compared to 7 (p = 0.02) and 21 (p = 0.009) days post-SICT in the 
SICT-positive group, but no significant difference between 7 and 21 days post-SICT (Fig 6a). 
Similarly, there was significantly (p = 0.04) lower IFN-ɣ release in response to aPPD in the SICT-
positive cattle at 78 days post-SICT compared to 21 days post-SICT; however, no significant 
differences were observed between the other time points (Fig 6b). Also, there was no significant 
difference in IFN-ɣ levels in the differential response to bPPD and aPPD in the SICT-positive cattle 
between any time points and no significant differences (p > 0.05; Wilcoxon matched pair test) were 
observed in IFN-ɣ release in the SICT-negative groups at any time point.  






















































































































Figure 6: IFN-ɣ release measured with Bovigam® at 7, 21 and 78 days post-SICT in response to whole 
blood stimulation with bPPD, aPPD and saline (Nil). Graphs present ODbPPD – ODNil in SICT-positive (a) and 
–negative groups (b); ODaPPD – ODNil in SICT-positive (c) and –negative groups (d); and ODbPPD – ODaPPD in 
SICT-positive (e) and –negative groups (f). There were significant differences (p < 0.05; Wilcoxon matched 
pair test) between groups represented with a bracket and p-value. Horizontal bars represent medians. 
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4.2.2.2 Temporal changes in QFT test outcomes (IFN-ɣ and IP-10) 
IFN-ɣ and IP-10 concentrations were measured by ELISA after whole blood stimulation in QFT 
tubes at 7, 21 and 78 days post-SICT. The median IFN-ɣ concentrations [QFTTB – QFTNil] of SICT-
positive cattle at 7, 21 and 78 days were 22.8 pg/ml (IQR: 10.9 to 39.7 pg/ml), 38.18 pg/ml (IQR: 
4.5 to 83.5 pg/ml) and 18.9 pg/ml (IQR: 7.1 to 78.2 pg/ml), respectively, and for the SICT-negative 
cattle, the medians were 28.7 pg/ml (IQR: 4.6 to 219 pg/ml), 18.3 pg/ml (IQR: 5.4 to 115.1 pg/ml) 
and 41.8 pg/ml (IQR: 4.4 to 371.5 pg/ml), respectively. The median IP-10 concentrations [QFTTB – 
QFTNil] of the SICT-positive animals at 7, 21 and 78 days post-SICT were 238.5 pg/ml (IQR: -8.1 to 
1366 pg/ml), 936.3 pg/ml (IQR: 41.4 to 2202 pg/ml) and 823.9 pg/ml (IQR: 98.2 to 2288 pg/ml), 
respectively. There were no significant differences (p > 0.05; Wilcoxon matched pair test) in IFN-ɣ 
or IP-10 release between 7, 21 and 78 days in the SICT-negative and SICT-positive groups, 
respectively. Also, no significant differences (p > 0.05; Mann-Whitney U test) were observed 
between the SICT-positive and –negative groups at any time point. Moreover, there were a number 
of responders from both the SICT-positive and SICT-negative groups in the QFT IFN-ɣ and IP-10 
assays (Fig 7). 











































































Figure 7: Release of IFN-ɣ in the SICT-positive (a) and –negative (b) cattle, and IP-10 in SICT-positive (c) 
and –negative (d) animals, in whole blood stimulated in QFT tubes [QFTTB – QFTNil] at 7, 21 and 78 days 
post-SICT. Both SICT-negative and SICT-positive groups had responder animals. Diagnostic cut-off values 
are indicated as dotted lines. Horizontal bars represent median values. 
 
Since the time between 7 and 21 days post-SICT was of limited duration and there was no 
significant difference in cytokine release between these time points, results from days 7 and 21 
were combined to compare these with results from day 78. Animals were defined as QFT-positive 
if they tested positive at either 7 or 21 days; and QFT-negative if they tested negative at both time 
points. Of the 33 animals in group 2, 12 (36.4%) cattle tested QFT IFN-ɣ positive at either day 7 or 
21; of these 12, only 5 animals tested positive at 78 days post-SICT (Table 8). There was no 
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significant difference (p = 0.55) in the proportion of QFT IFN-ɣ positive animals from 7 or 21 days 
(36.4%) and 78 days post-SICT (27.3%), as determined by McNemars’s test. Also, 21 out of 33 
(63.6%) animals tested QFT IFN-ɣ-negative at both 7 and 21 days post-SICT and of these, 17 
(81%) tested negative at 78 days post-SICT (Table 8). The majority of QFT IFN-ɣ negative cattle at 
7 and 21 days remained negative at 78 days post-SICT (81%), providing confidence in the 
negative result. However, agreement between the 7/ 21 day and 78 day time points was poor 
(Cohen’s kappa = 0.15). 
Using the IP-10 assay, 12 of 33 (36.4%) animals tested QFT-positive at 7 or 21 days post-SICT. Of 
these, only 7 cattle tested positive at 78 days post-SICT (Table 8). Also, similar to the QFT IFN-ɣ 
results, there was no significant difference (p = 1.0, McNemar’s test) in the proportion of QFT IP-10 
positive animals from 7 or 21 days (36.4%) and 78 days post-SICT (33.3%). Furthermore, 21 of 33 
animals (63.6%) were IP-10 negative at 7 and 21 days post-SICT. Of these, 17 animals (81%) 
were test-negative at 78 days post-SICT, similar to QFT IFN-ɣ assay results. Agreement between 
the 7/ 21 day and 78 day time points was low (Cohen’s kappa = 0.32).  
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Table 8: QFT IFN-ɣ and QFT IP-10 test outcomes at 7 or 21 days and 78 days post-SICT of cattle that were 
test positive at any time point on either QFT IFN-ɣ or IP-10 assays 
  QFT IFN-ɣ QFT IP-10 












+ - - - 
2 + - + + 
3 + - - - 
4 + - + - 
5 + + + + 
6 + + + + 
7 - + - - 
8 - + - - 
9 - - + - 
10 - - - + 
11 - - + + 
12 - - + - 













+ + + + 
15 + + + + 
16 + + + + 
17 + - - - 
18 + - + - 
19 + - - - 
20 - + - + 
21 - + - + 
22 - - - + 
 
ʺ+ʺ, Test-positive; ʺ-ʺ, Test-negative 
 
4.2.2.3 SICCT outcome 
Single intradermal comparative cervical tuberculin tests (SICCTs) were performed at 78 days post-
SICT on both the SICT-positive and SICT-negative cattle groups at the time of blood collection. 
Only 4 of 16 animals from the original SICT-positive group were SICCT-positive (25%) and none 
from the SICT-negative group. The number of SICCT-positive animals was significantly greater (p 
= 0.04; Fisher’s exact test) in the SICT-positive group than in the SICT-negative group. 
Furthermore, there were significantly greater changes in SFT (Δ SFT) in the SICT-positive group 
compared to the SICT-negative group (Fig 8a) at the bPPD (p < 0.0001; Mann-Whitney U test) and 
aPPD (p = 0.004; Mann-Whitney U test) sites, respectively. Also, the median SFT at the bPPD site 
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(median = 4.8 mm; IQR: 3.3 to 6.1) was significantly greater (p = 0.0005; Wilcoxon matched pair 
test) than at the aPPD site (median = 1.9 mm; IQR: 0.9 to 3.2) in the SICT-positive group. 
Moreover, the differential increase in SFT between the bPPD and aPPD sites (SFTbPPD – SFTaPPD) 
(Fig 8b) was significantly greater (p < 0.0001) in the SICT-positive group (median = 2.55 mm; IQR: 
1.5 to 4.3) than in the SICT-negative group (median = 0 mm; IQR: -0.7 to 1.2), as determined by 
the Mann-Whitney U test.  
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Figure 8: Change in skin fold thickness (SFT; mm) between 0 to 3 days post-SICCT in response to bPPD 
and aPPD in SICT-positive and SICT-negative cattle (a). Significant differences, as determined by Mann-
Whitney U test, are indicated by bars and p-values. Significant differences (p < 0.05; Wilcoxon signed rank 
test) were observed in the differential response to bPPD and aPPD (SFTbPPD - SFTaPPD) (b). Horizontal bars 
represent medians. 
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4.3 Changes in antigen-induced cytokine release in African buffaloes 
following the SICCT 
4.3.1 Animals 
The release of IP-10 and IFN-ɣ in response to Bovigam® antigens was measured pre-SICCT (day 
0) and post-SICCT (day 3) to investigate the effect of the SICCT on cytokine production and test 
outcome of in vitro diagnostic assays in buffaloes (n = 286). Animals were divided in groups 
according to their day 0 test outcome. Group 1 consisted of 55 buffaloes that tested positive on any 
Bovigam® ELISA, i.e. the PPD, PC-HP or PC-EC assays, regardless of the SICCT result. Group 2 
served as a negative control group and consisted of 21 buffaloes that tested negative on all 
Bovigam® assays and on SICCT. Group 3 consisted of five buffaloes that were SICCT-positive, 
but Bovigam®-negative. 
All buffaloes from groups 1 and 3 were slaughtered, tissue samples were cultured and speciation 
was performed. Thirty of 55 group 1 buffaloes (55%) and 2 of 5 group 3 buffaloes (40%) were M. 
bovis-positive on culture. Due to limited stimulated blood for some animals, all assays were not 
performed on all animals. 
4.3.2 Effect of the SICCT on absolute IFN-ɣ concentrations in response to PPD and 
PC-HP 
The change in IFN-ɣ release in response to bPPD, aPPD and PC-HP from pre- to post-SICCT was 
measured by the Mabtech IFN-ɣ ELISA in 55 animals from group 1 and 21 buffaloes from group 2. 
The median IFN-ɣ concentrations (pg/ml) in response to these antigens for animals from group 1 
are presented in Table 9, and from group 2 in Table 10.  
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Table 9: Median concentrations (pg/ml) and interquartile range (IQR) of IFN-ɣ release in response to 
Bovigam® antigens pre- and post-SICCT for buffaloes from group 1, i.e. Bovigam®-positive on any assay 
pre SICCT. 
 Pre-SICCT Post-SICCT 
Condition Median IQR Median IQR 
bPPD – Nil 903.7 191.2 to 2191 395.7 148.9 to 996.9 
aPPD – Nil 79.54 37.58 to 204 71.6 29.4 to 158 
bPPD – aPPD 785.6 181.6 to 2050 287.9 79.8 to 796.6 
HP – Nil 559.2 96.9 to 1628 171.4 38.67 to 370.9 
 
Table 10: Median concentrations (pg/ml) and interquartile range (IQR) of IFN-ɣ release in response to 
Bovigam® antigens pre- and post-SICCT for buffaloes from group 2, i.e. pre-SICCT negative on all 
Bovigam® assays and SICCT. 
 Pre-SICCT Post-SICCT 
Antigen Median IQR Median IQR 
bPPD – Nil 44.02 0 to 107.2 43.14  2.6 to 71 
aPPD – Nil 57.5 0 to 80.5 45.5 22.8 to 75.9 
bPPD – aPPD 0 -22.4 to 33.5 -10.8 -26.7 to 8.6 
HP – Nil 0 0 to 12.52 0.4 0 to 18.3 
 
Using the Wilcoxon signed rank test, a significant decrease (p < 0.0001) in IFN-ɣ release in 
response to bPPD (Fig 9a) and in the differential response to bPPD and aPPD (Fig 9c) was 
observed from pre- to post-SICCT for animals from group 1. However, there were no significant 
differences (p = 0.09) in the median IFN-ɣ concentration between these time points in response to 
aPPD (Fig 9b). Furthermore, a significant decrease (p < 0.0001) in response to PC-HP was 
observed from pre- to post-SICCT (Fig 9d). For group 2, no significant differences (p > 0.05) in 
IFN-ɣ release between pre- and post-SICCT were observed.   
Stellenbosch University  https://scholar.sun.ac.za
51 
 





























































































Figure 9: IFN-ɣ release (pg/ml) in response to a) bPPD, b) aPPD, c) bPPD – aPPD and d) PC-HP as 
measured by Mabtech IFN-ɣ ELISA pre- and post-SICCT in groups 1 and 2. Differences between pre- and 
post-SICCT time point concentrations were compared using the Wilcoxon signed rank test. Horizontal lines 
represent medians.  
4.3.3 Effect of the SICCT on the Bovigam® test outcome 
Forty-nine buffaloes from group 1, 21 buffaloes from group 2 and 5 buffaloes from group 3 were 
tested by the Bovigam® assay to measure the change in IFN-ɣ release from pre- to post-SICCT in 
response to bPPD, aPPD and PC-HP and PC-EC peptides, respectively. Median OD values of 
IFN-ɣ levels in response to these antigens for group 1 are shown in Table 11 and for group 2 in 
Table 12. For group 3, median OD values of IFN-ɣ in response to bPPD at pre- and post-SICCT 
were 0.09 (IQR: 0.06 to 0.2) and 0.4 (IQR: 0.16 to 1.4), respectively, and that of the differential 
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response to bPPD and aPPD at pre- and post-SICCT, were 0.08 (IQR: 0.04 to 0.09) and 0.3 (IQR: 
0.1 to 1.1), respectively.  
Table 11: Median OD values and interquartile range (IQR) of IFN-ɣ release in response to Bovigam® 
antigens pre- and post-SICCT for buffaloes from group 1, i.e. Bovigam®-positive at pre-SICCT time point. 
 Pre-SICCT Post-SICCT 
Condition Median IQR Median IQR 
ODbPPD - ODNil 0.9 0.22 to 1.9 0.5 0.15 to 0.96 
ODbPPD - ODaPPD 0.8 0.2 to 1.6 0.38 0.04 to 0.84 
ODaPPD – ODNil 0.08 0.03 to 0.2 0.06 0.02 to 0.19 
ODHP – ODNil 0.3 0.09 to 1.0 0.18 0.002 to 0.3 
ODEC – ODNil 0.36 0.1 to 0.96 0.1 0.01 to 0.3 
 
 
Table 12: Median OD values and interquartile range (IQR) of IFN-ɣ in response to Bovigam® antigens pre- 
and post-SICCT for buffaloes from group 2, i.e. Bovigam® and SICCT-negative. 
 Pre-SICCT Post-SICCT 
Antigen Median IQR Median IQR 
ODbPPD - ODNil 0.01 -0.002 to 0.05 0.04 0.02 to 0.1 
ODbPPD - ODaPPD 0.002 -0.01 to 0.02 -0.02 -0.04 to 0.03 
ODaPPD – ODNil 0.009 0 to 0.03 0.05 0.02 to 0.18 
ODHP – ODNil -0.004 -0.01 to 0.01 0.004 -0.01 to 0.02 
ODEC – ODNil -0.002 -0.01 to 0.006 0.005 -0.03 to 0.02 
 
Using the Wilcoxon signed rank test for group 1, significant decreases in IFN-ɣ levels in response 
to bPPD (ODbPPD – ODNil) (p = 0.0008; Fig 10a) and in the differential response to bPPD and aPPD 
(ODbPPD – ODaPPD) (p = 0.0006; Fig 10c) were observed from pre- to post-SICCT. However, there 
was no significant difference (p = 0.5; Fig 10b) in IFN-ɣ release in response to aPPD (ODaPPD - 
ODNil) between these time points (Fig 9b). Furthermore, IFN-ɣ levels produced in response to PC-
HP (ODHP – ODNil; Fig 11a) and PC-EC (ODEC – ODNil; Fig 11b) decreased significantly (p < 
0.0001) from pre- to post SICCT. In groups 2 and 3, no significant differences (p > 0.05; Wilcoxon 
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signed rank test) in IFN-ɣ levels in response to any Bovigam® antigen were observed between 
these time points.  
































































Figure 10: IFN-ɣ release in response to a) bPPD (ODbPPD – ODNil), b) aPPD (ODaPPD – ODNil) and c) the 
differential response to these antigens (ODbPPD – ODaPPD) pre-SICCT and post-SICCT as measured by the 
Bovigam® assay in animals from group 1, i.e. Bovigam®-positive at the pre-SICCT time point, and group 2, 
i.e. Bovigam® and SICCT-negative. Differences in median OD were compared using Wilcoxon matched pair 
test. Horizontal bars represent medians. 
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Figure 11: IFN-ɣ release in response to a) PC-HP (ODHP – ODNil) and b) PC-EC (ODEC – ODNil) pre-SICCT 
and post-SICCT as measured by Bovigam® in animals from group 1, i.e. pre-SICCT Bovigam®-positive, and 
group 2, i.e. Bovigam® and SICCT-negative. Differences in median OD were compared using Wilcoxon 
matched pair test. Horizontal bars represent medians. Diagnostic cut-off values, i.e. 0.1, are indicated by the 
dotted line.  
 
The proportions of test-positive and –negative animals from group 1 pre- and post-SICCT are 
summarised in Table 13. Significantly greater proportions of animals tested positive pre-SICCT 
compared to post-SICCT on the Bovigam® PPD (p = 0.046) and PC-EC assays (p = 0.0036), but 
not with the Bovigam® PC-HP assay (p = 0.08), as determined by McNemar’s test. Post-SICCT 
test outcomes of group 2 showed that 1 of 21 (4.8%) buffaloes were Bovigam® PPD positive, none 
were PC-HP positive and 2 of 21 (9.5%) buffaloes were PC-EC positive. However, there were no 
significant changes (p > 0.05; McNemar’s test) in test outcome (Bovigam® PPD, PC-EC and PC-
HP assays) between pre- and post-SICCT for group 2. In group 3, 4 of 5 buffaloes (80%) were 
Bovigam® PPD-positive post-SICCT and 3 of 5 (60%) animals were positive on the PC-HP and 
PC-EC assays, respectively. These 3 animals were the same individuals on both assays. The 
proportion of test-positive animals was, however, not significantly different (p > 0.05; McNemar’s 
test) between the 2 time points.  
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Table 13: Proportions of test-positive and –negative buffaloes pre- and post-SICCT from group 1 as 
determined by Bovigam® PPD, PC-EC and PC-HP assays.  
 Test-positive Test-negative 
Bovigam® assay Pre-SICCT Post-SICCT Pre-SICCT Post-SICCT 
PPD 40/48 (83%) 33/48 (69%) 8/48 (17%) 15/48 (31%) 
PC-EC 38/49 (78%) 25/49 (51%) 11/49 (22%) 24/49 (49%) 
PC-HP 35/48 (73%) 27/48 (56%) 13/48 (27%) 21/48 (44%) 
 
Relative sensitivities were calculated as the proportion of Bovigam®-positive animals from those 
that were M. bovis-positive and/ or had BTB-like lesions with a score of 2 (several small foci or a 
single large lesion) or 3 (multifocal or confluent lesions) (W. Goosen pers. comm.).  
For the Bovigam® PPD assay, there was no significant change (p = 0.2; McNemar’s test) in 
relative sensitivity from pre-SICCT (96.7%; CI: 82.8 – 99.9%) to post-SICCT (86.7%; CI: 69.3 – 
96.2%). Similarly, there were no significant differences (p = 0.4; McNemar’s test) in relative 
sensitivity between pre-SICCT (83.3%; CI: 65.3 – 94%) and post-SICCT (73.3; CI: 54.1 – 87.7%) 
for the Bovigam® PC-HP assay or between pre-SICCT (83.9%; CI: 66.3 – 94.6%) and post-SICCT 
(64.5%; 45.4 – 80.8%) for the Bovigam PC-EC assay (p = 0.08; McNemar’s test).   
4.3.4 Change in IP-10 production and test outcome from pre-SICCT to post-SICCT 
IP-10 concentrations in response to PC-EC peptides were measured pre- and post-SICCT in 49 
buffaloes from group 1 and 17 animals from group 2. The median IP-10 concentrations for animals 
from group 1 pre- and post-SICCT were 8171 pg/ml (IQR: 2063 to 10044) and 3135 pg/ml (1105 to 
7964), respectively. The median IP-10 concentrations for animals from group 2 pre- and post-
SICCT were 261 pg/ml (-266.4 to 656.2) and 84.55 pg/ml (-92.3 to 385), respectively. In group 1, 
IP-10 concentration decreased significantly (p = 0.0005) from pre- to post-SICCT (Fig 12), but no 
significant difference (p = 0.7) was observed between these time points for group 2, as determined 
by the Wilcoxon signed rank test.  
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Using a diagnostic cut-off value of 2258 pg/ml (W. Goosen, pers. comm.), 37 of 49 (75.5%) 
buffaloes from group 1 were IP-10 positive pre-SICCT, of which 30 buffaloes plus no additional 
animals (61.2%) tested positive post-SICCT. The proportion of IP-10 positive animals was 
significantly greater pre-SICCT than post-SICCT (p = 0.02; McNemar’s test). No animals from 
group 2 were IP-10 positive pre- or post-SICCT. The relative sensitivity of the IP-10 assay 
decreased significantly (p = 0.04; McNemar’s test) from pre-SICCT (96.9%; CI: 83.8 – 99.9%) to 
post-SICCT (78.1%; CI: 60 – 90.7%). This was calculated as the proportion of IP-10 positive 
animals that were culture positive and/or had visible lesions with a score of 2 (several small foci or 
a single large lesion) or 3 (multifocal or confluent lesions, as previously described (Palmer et al., 
2007)  


















Figure 12: IP-10 release (pg/ml) in response to PC-EC pre- and post-SICCT in groups 1 and 2. A significant 
difference (p < 0.0001; paired t test) between pre- and post-SICCT was observed in group 1. The diagnostic 
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4.3.5 Change in cortisol release from pre- to post-SICCT 
Cortisol levels in serum samples were measured by a commercial competitive ELISA at the pre-
SICCT and post-SICCT time points in 14 buffaloes that showed the greatest increase (Group A) 
and 18 buffaloes that showed the greatest decrease (Group B) in IFN-ɣ production from pre- to 
post-SICCT on the Bovigam® assay. The mean cortisol concentrations (ng/ml) pre- and post-
SICCT of group A were 540.1 (standard deviation, SD: 439.2) and 595.8 (SD: 470.9), respectively, 
whereas the mean cortisol concentrations of group B pre- and post-SICCT were 758.6 (SD: 692.6) 
and 599.4 (SD: 563.2), respectively. No significant differences (p > 0.05; paired t test) in cortisol 
concentrations were observed between the pre- and post-SICCT time points in group A and group 
B (Fig 13). Also, there were no significant differences (p > 0.05; unpaired t test) in cortisol 
concentrations between group A and group B at either time points (Fig 13).   



















Figure 13: Cortisol concentration (ng/ml) as measured by a commercial competitive ELISA pre- and post-
SICCT for buffaloes with an increase (Group A; n = 18) and a decrease (Group B; n = 18) in IFN-ɣ 
production on the Bovigam® assay. Horizontal lines represent means. 
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Chapter 5: Discussion  
5.1 Progression of immunological responses in naturally M. bovis-infected 
African buffaloes 
Animals that displayed chronic Bovigam®-positivity (group 1) showed good agreement between 
test outcomes for the Bovigam®, QFT IFN-ɣ and QFT IP-10 assays. In contrast, animals which 
showed recent conversion to Bovigam®-positivity (group 2) and those classified as Bovigam®-
negative (group 3), showed poor agreement between Bovigam® and QFT test outcomes.  
Interestingly, all the chronically Bovigam®-positive buffaloes were consistently QFT IP-10 and QFT 
IFN-ɣ positive at all six captures for the one year period, whereas the majority of newly Bovigam®-
positive animals were consistently QFT IP-10 and QFT IFN-ɣ negative. Also, the magnitude of IFN-
ɣ and IP-10 release did not change significantly over time in either group. Other studies reported a 
significant increase in IFN-ɣ release between two to eight weeks after experimental infection of 
cattle, which remained elevated until the end of the 20 – 22 week study duration, at which point the 
cattle had developed BTB-like lesions (Buddle et al., 1995; Pollock and Andersen, 1997b; Rhodes 
et al., 2000b, 2000c). Also, IFN-ɣ release in response to bPPD and ESAT-6 was similar throughout 
the infection period (Rhodes et al., 2000a, 2000b, 2000c; Vordermeier et al., 2002; Waters et al., 
2010). Since the buffaloes from group 1 were already Bovigam®-positive before inclusion in the 
study, we do not know when an increase in IFN-ɣ release in response to PPD and ESAT-6 
occurred. However, similar to the cattle studies, this group remained IFN-ɣ and IP-10 positive 
throughout the study. Group 1 buffaloes probably did not have advanced BTB, since it has been 
shown that IFN-ɣ release decrease at advanced stages of disease in chronically M. bovis-infected 
cattle; in some cases this may result in a negative test result (Welsh et al., 2005). The results from 
group 2 did not agree with the cattle studies. These buffaloes were Bovigam® PPD positive for 
approximately four months prior to inclusion in the study and for another six months during the 
study, but remained QFT-negative. Since the cattle studies showed that there was no significant 
difference in IFN-ɣ release in response to ESAT-6 or bPPD, we speculate that the difference in 
response between the two antigens may be due to exposure or infection with environmental 
mycobacteria. Environmental mycobacteria have been shown to cause a decrease in specificity of 
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the Bovigam® PPD assay (Buddle et al., 2009; Thom et al., 2004; Wood and Jones, 2001). 
However, ESAT-6 and CFP-10 have been used to increase specificity of CRAs, since the RD1 
genes encoding these proteins are deleted from most environmental mycobacteria, with a few 
exceptions (Pollock and Andersen, 1997a; Thom et al., 2004; Waters et al., 2004). Therefore, with 
a lower specificity, the Bovigam® assay could be identifying greater numbers of false-positive 
animals, whereas the QFT result may reflect the true result for this group, i.e. M. bovis-uninfected. 
Another possible explanation for the group 2 results is that the buffaloes had a low level infection 
and the response to the ESAT-6 and CFP-10 antigens were present, but not at sufficient levels to 
exceed the threshold of detection in the assay.  
The majority of animals from the Bovigam®-negative group (group 3) were QFT IFN-ɣ negative, 
but QFT IP-10 positive. Therefore, both tests that measured IFN-ɣ resulted in a negative test 
result, whereas the assay that measured IP-10 resulted in a positive test result. IP-10 is typically 
upregulated by IFN-ɣ and occurs in significantly greater concentrations, about 100-fold greater, in 
stimulated blood compared to IFN-ɣ (Chakera et al., 2011; Chegou et al., 2014; Ruhwald et al., 
2009). Therefore, if the buffaloes were in the early stage of M. bovis-infection, antigen-specific T-
lymphocyte numbers could be low, which would result in low IFN-ɣ production. However, even at 
low levels, IFN-ɣ can result in the activation of IP-10 release that is high enough to be detected by 
ELISA  (Goosen et al., 2014). Therefore, we speculate that this group may have been early M. 
bovis-infected animals, which could result in detection of IP-10 but low (undetectable) levels of 
IFN-ɣ. However, as described in cattle studies, significant increases in cytokine release were 
observed two to eight weeks post-infection (Buddle et al., 1995; Pollock and Andersen, 1997b; 
Rhodes et al., 2000b, 2000c). We would therefore expect to have seen a response during the 12 
month period in which they were sampled. A possible explanation for this discrepancy is that cattle 
in the previously mentioned studies were experimentally infected, which may have resulted in 
exposure to greater numbers of M. bovis organisms than the buffaloes from our field study. This 
would lead to IFN-ɣ responses at an earlier time point post infection than in a natural system. This 
hypothesis is supported by findings of Rhodes et al. (2000c), in which cattle that were 
experimentally infected with very low doses of M. bovis showed no significant increase in IFN-ɣ 
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release by 20 weeks post-infection. It may therefore indicate that variation in time for antigen-
specific cytokine responses to take place after infection may be related to mycobacterial load and 
disease development. 
The immune response to M. bovis typically involves a dominating T helper type 1 (Th1) CMI 
response in early stages of infection, which is associated with high levels of IFN-ɣ release. As 
disease progresses, a more dominant T helper type 2 (Th2) response develops, associated with a 
decreased CMI response (decreased IFN-ɣ release) and an increase in the humoral response  
(Palmer et al., 2006; Pollock et al., 2005; Welsh et al., 2005; Wood and Jones, 2001). Welsh et al. 
(2005) further showed that antibody responses developed shortly (approximately 2 weeks) after 
the initial CMI response in the early stages of infection, followed by a decrease in IFN-ɣ release in 
response to bPPD, and increased antibody levels as disease progressed in cattle. However, our 
study showed that there was no significant change in cytokine release or antibody levels during the 
1 year study period in any of the three groups of buffaloes. Also, in contrast to the cattle studies, 
there was no significant correlation between QFT IFN-ɣ and QFT IP-10 release and antibody levels 
for chronically infected buffaloes (group 1) over time. Furthermore, the IFN-ɣ and IP-10 responses 
fluctuated between animals and over time, as observed by others (Rhodes et al., 2000b; Waters et 
al., 2006). One buffalo from group 3 was euthanised due to respiratory compromise and lesions 
characteristic of BTB were found at necropsy. This buffalo was QFT-positive, but Bovigam®-
negative. This may have been caused by a high response to aPPD due to exposure or infection 
with environmental mycobacteria, resulting in a false-negative Bovigam® PPD test result. Although 
this animal had gross evidence of disease, there was no significant change in IFN-ɣ and IP-10 
release or in circulating antibody levels over time. QFT IFN-ɣ and QFT IP-10 assay results did, 
however, remain positive and antibody levels were similar to the median ODs of all three groups. 
These findings did not agree with Welsh et al. (2005) that showed that antibody levels correlated 
with the development of pathology in experimentally infected cattle, while IFN-ɣ was a poor 
indicator of pathology at advanced stages of disease (Welsh et al., 2005).  In our study, the QFT 
assays correctly identified the buffalo with BTB pathology, whereas antibody levels remained 
unchanged. Other studies also found that circulating antibody levels to bPPD remained low and 
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unchanged for the duration of disease development, even though the cattle had BTB lesions on 
post-mortem examination (Buddle et al., 1995). From our study, we believe that a one year period 
may not be long enough to see significant changes in antibody and cytokine release in a naturally 
M. bovis exposed group of Bovigam®-positive buffaloes. However, since the Bovigam®-positive 
buffaloes had detectable CMI responses throughout the study period, but not strong antibody 
responses, and QFT assays correctly identified the buffalo with BTB, we recommend that 
diagnostic assays based on the CMI response, rather than the humoral response, should be used 
for the early diagnosis of BTB in buffaloes, which is supported by findings of other studies (de la 
Rua-Domenech et al., 2006; Palmer et al., 2006; Welsh et al., 2005). Furthermore, using both PPD 
and ESAT-6 antigens in diagnostic assays for disease surveillance would improve the sensitivity 
and specificity to correctly identify test-positive animals, even when environmental mycobacteria 
are present or infection levels are low (Parsons et al., 2011; Wood and Jones, 2001). Also, 
including assays that measure IP-10 release would allow detection of buffaloes at earlier stages of 
disease than with IFN-ɣ assays. 
There were some limitations in this study. Most importantly was the small sample size of all three 
groups used in this study, which may have influenced our results in investigating the temporal 
changes in immune responses in these animals. Naturally M. bovis-infected or exposed buffaloes 
were used for the study. Therefore, we did not know how long these animals had been infected. 
Also, since there were no necropsy or culture results for these animals, we were unable to 
determine the true infection status of the animals. However, the presence of BTB lesions in one 
study buffalo confirmed the presence of disease in the herd.  
In summary, there was no significant change in IFN-ɣ or IP-10 release or in circulating antibody 
levels for the duration of the study, even in the case of confirmed BTB disease. A one-year study 
period appeared to be an insufficient duration to investigate changes in immune responses in 
Bovigam®-positive buffaloes. Results from chronically Bovigam®-positive animals (i.e. animals 
suspected to have chronic infection) showed good agreement between the QFT IFN-ɣ, QFT IP-10 
and Bovigam® assays. However, results from the group of animals that recently converted to 
Bovigam®-positivity showed poor agreement between the Bovigam® and QFT assays, which may 
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have been associated with exposure to environmental mycobacteria. Finally, results from group 3 
buffaloes (Bovigam®-negative) showed poor agreement between the IP-10 and IFN-ɣ assays, 
which could be attributed to greater IP-10 sensitivity at early stages of infection. Based on our 
limited findings, serial testing with consistent positive responses may increase confidence in 
determining true infection status in buffaloes, although changes in cytokine levels may vary over 
time. Further studies are needed to understand trends in cytokine release over time in naturally 
infected buffaloes.  
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5.2 Temporal changes in antigen-induced cytokine release in cattle 
In SICT-positive cattle, high levels of PPD-specific (bPPD and aPPD) IFN-ɣ release occurred 1 – 3 
weeks following the SICT and declined thereafter, suggesting immunological boosting by the skin 
test. Our results share similarities with Whipple et al. (2001) who reported a boost of IFN-ɣ in 
response to bPPD and aPPD between 3 and 28 days post-CFT, which declined thereafter. In 
contrast, Palmer et al. (2006) showed that the boosting effect lasted only between 3 and 7 days 
post-CFT, after which IFN-ɣ levels decreased. Furthermore, our results were similar to studies that 
reported a decline in IFN-ɣ release from 3 days post-SICCT (Whelan et al., 2004) and between 1 
and 28 days post-SICCT (ÓNualláin et al., 1997). However, it seems more likely that the SICT 
caused a boost in IFN-ɣ release, followed by a decrease, since results from study cohort 2 showed 
an increase in IFN-ɣ release from 7 to 21 days post-SICT (not significant) followed by a significant 
decline in IFN-ɣ release by 78 days post-SICT. However, our result differed from studies that 
showed that the TST caused a boost in IFN-ɣ until 59 days post-CFT (Rothel et al., 1992; Wood 
and Rothel, 1994) or had no effect on IFN-ɣ production (Coad et al., 2010; Doherty et al., 1995; 
Gormley et al., 2004; Ryan et al., 2000). Moreover, Thom et al. (2006) reported a more 
pronounced IFN-ɣ boost in response to aPPD than in bPPD up to 7 days post-SICCT in M. bovis-
positive cattle. In our study, the SICT-negative cattle were unaffected by the SICT, which agrees 
with other studies (Palmer et al., 2006; Thom et al., 2006).  
Although we used animals from the same cattle herd, there were conflicting results between our 
two study cohorts when investigating the effect of the SICT on IFN-ɣ and IP-10 release in response 
to specific antigens, ESAT-6 and CFP-10. In the SICT-positive cattle from the first study cohort, 
high levels of IFN-ɣ were released 6 days after the SICT, which declined significantly by 41 days, 
again suggesting immunological boosting by the skin test. Our results were similar to other studies 
that reported a decline in IFN-ɣ release in response to ESAT-6 and CFP-10, from 7 days post-CFT 
(Palmer et al., 2006) and 3 days post-SICCT (Whelan et al., 2004). Our results differed from 
studies that found that the SICCT had no effect on IFN-ɣ production in response to ESAT-6 and 
CFP-10 (Coad et al., 2007; Thom et al., 2006). However, this observation was consistent with 
results from the second study cohort, which showed that there was no immunological boosting of 
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IFN-ɣ or IP-10, following the SICT, in the SICT-positive and negative groups. To our knowledge, 
this was the first study to investigate the effect of the SICT on IP-10 production in cattle. 
The boosting effect of the SICT appears to affect cytokine production differently in response to 
specific antigens (ESAT-6, CFP-10) compared to PPDs. The number of QFT-positive, but not the 
Bovigam®-positive, animals decreased as the effect of the SICT diminished significantly by 41 
days post-SICT. Also, by 41 days post-SICT, cattle which were culture-negative for M. bovis were 
all QFT IFN-ɣ negative, 6/29 were IP-10 positive, but 22/29 were Bovigam®-positive, indicating the 
high specificity of the QFT assays, especially the QFT IFN-ɣ assay, at this time point post-SICT. In 
fact, we found that the relative specificities of the QFT IFN-ɣ and QFT IP-10 assays, used alone or 
in combination, increased significantly by 41 days following SICT.  
In the second study cohort, however, the SICT had no significant effect on test outcome and there 
was no significant difference in cytokine release between the SICT-positive and –negative groups. 
In addition, cytokine test-positive cattle were detected in both groups. Unfortunately, it is unknown 
whether there were any truly infected animals in the second study cohort, according to the gold 
standard, since they were not slaughtered. Possible explanations for the detection of CRA-positive 
animals in the SICT-negative group could be due to variation in the amount of time individuals may 
have been exposed or infected, or number of SICTs performed in these individuals. Test-positive 
cattle could also have been early-infected animals, since significant IFN-ɣ reactions can be 
detected by 15 days after M. bovis-infection, whereas a TST response is generally seen three to 
six weeks after infection (de la Rua-Domenech et al., 2006; Monaghan et al., 1994; Palmer et al., 
2006).  
The conflicting results between the two study cohorts and between the QFT and Bovigam® results 
may be due to exposure or infection with environmental mycobacteria, as indicated by the high 
aPPD response measured by Bovigam® in both study cohorts. Animals that are exposed or 
infected with environmental mycobacteria may also show a positive response to bPPD, since many 
of the antigens that are present in bPPD are shared between environmental mycobacteria and M. 
bovis (Pollock et al., 2005; Schiller et al., 2010). Pollock and Anderson (1997a) also demonstrated 
that cattle sensitised to environmental mycobacteria reacted to bPPD and aPPD, but not to ESAT-
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6 (Pollock and Andersen, 1997a). Therefore, the QFT assay, which incorporates ESAT-6 and CFP-
10, should be able to distinguish between M. bovis-infections and environmental mycobacterial 
infections. We speculate that the immunological boosting effect that was seen in the Bovigam® 
assays following the SICT, may have been in response to sensitisation by environmental 
mycobacteria, rather than a response to M. bovis infection. This hypothesis is supported by the 
large number of false-positive cattle detected by Bovigam® compared to the significantly lower 
number of QFT-positive cattle at 41 days post-SICT. The SICT also identified large numbers of 
false-positive animals, especially in the first study cohort, where all 29 cattle were M. bovis-culture 
negative, but SICT-positive. Since the SICT only use bPPD, and not aPPD, it does not allow 
differentiation between responses to environmental mycobacteria compared to responses to M. 
bovis, which would reduce specificity (Coad et al., 2010; Palmer et al., 2006).  
The large number of SICT-positive animals could also be due to repeated skin testing in this herd. 
Sensitisation to tuberculin following repeated skin tests has been reported in other studies (de la 
Rua-Domenech et al., 2006; Monaghan et al., 1994). The cattle herd used in our study was skin 
tested once per year, which is a much greater time interval than the recommended time of 60 days 
between TSTs (Coad et al., 2010; Ryan et al., 2000; Thom et al., 2006). Since the QFT assays are 
not affected by environmental mycobacteria, these results may be the more accurate 
representation of the test outcome of the assays. This explanation is supported by results from 
Palmer et al. (2006), which found that IFN-ɣ release was significantly lower in response to ESAT-6 
and CFP-10 when compared to bPPD in M. bovis-uninfected cattle following the TST.  
In order to minimise culling of false-positive cattle in herds with low BTB prevalence, it is important 
to have a diagnostic strategy that incorporates high specificity. The Bovigam® assay, which has 
reportedly high sensitivity (Wood and Jones, 2001), and the SICT, with its decreased specificity in 
herds exposed to environmental mycobacteria, were not suitable in this herd with low BTB 
incidence and suspected high environmental mycobacterial burden, since it identified large 
numbers of false-positive cattle. However, the QFT assays, especially the QFT IFN-ɣ assay, were 
more suitable for BTB control in this herd, since they had greater specificity and correctly identified 
all the animals from the first study cohort as test-negative on the QFT IFN-ɣ assay, with only a 
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small proportion of false-positive cattle on the IP-10 assay at day 41. Therefore, our results 
suggest that when performing serial testing, it is recommended to collect whole blood samples for 
the QFT IFN-ɣ assay at 41 days post-SICT, when the effect of the SICT has significantly 
decreased, to identify truly uninfected animals sooner than waiting to retest animals with the 
SICCT at 60 days (Coad et al., 2010; Palmer et al., 2006). Also, using the QFT IFN-ɣ assay at 41 
days post-SICT, rather than earlier, may minimise culling of false-positive cattle, which would be 
economically advantageous and provide a more accurate assessment of the SICT reactors. 
However, the 41 day post-SICT testing does not support the recommended time frame of 3 to 30 
days post-TST to collect blood for confirmatory in vitro assays (Palmer et al., 2006). 
Since the QFT assays appeared to have greater specificity, it is possible that the boosting effect of 
the SICT on these assays may be more useful in distinguishing truly infected from false-positive 
cattle. We investigated whether results from the 7 and 21 day time points of the QFT assays, which 
were combined as one time point, could be used to predict the outcome at 78 days post-SICT. We 
found that the results of 7/21 day time points from of the QFT IFN-ɣ and QFT IP-10 assays were 
poor indicators of positive test outcomes at 78 days post-SICT, since only 42% and 58% of the 
QFT IFN-ɣ and QFT IP-10, respectively, remained positive at 78 days post-SICT. However, the 7/ 
21 day time point results could accurately be used to predict a negative test outcome at 78 days 
post-SICT, since 81% of the animals remained test-negative at both time points.  
We would therefore recommend that the animals that were QFT-positive at 78 days post-SICT, 
especially the QFT-IFN-ɣ positive animals, should be regarded as suspect for BTB and be retested 
with the QFT assay at least 41 days following any skin testing. This is based on the QFT results 
from the first study cohort, which showed that the effect of the SICT diminished significantly by 41 
days following the SICT, and the Bovigam® results of the second study cohort in which the test 
outcome was still affected by 21 days post-SICT. However, by 78 days post-SICT, the results did 
not appear to be significantly affected by the SICT. Therefore, the test results from this later time 
point should more accurately reflect the infection status of the individual. 
One of the limitations of this study was that the initial categorisation of cattle in the study cohorts 
was based on the SICT, not the SICCT. Results from the subsequent SICCT in the second study 
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cohort showed that the cattle were exposed to, or infected with environmental mycobacteria, since 
the response to aPPD was high. Only 4 cattle from the initial SICT-positive group of the second 
study cohort (n = 16) were SICCT-positive. SICCTs can distinguish between M. bovis infected 
animals and those that are exposed to, or infected with environmental mycobacteria, since the 
response to aPPD is considered in the test criteria (Gormley et al., 2006; Palmer et al., 2006; 
Thom et al., 2006). The change in SFT was significantly greater in the SICT-positive group 
compared to the negative group in response to both aPPD and bPPD; in addition, the SICCT-
positive animals all came from the SICT-positive group. Therefore, the SICT did identify high 
responding (i.e. suspect) animals, which could be further tested using the SICCT. Applying the 
SICCT to only SICT-positive animals would decrease the cost and time of testing the entire herd 
with the SICCT, which requires two injections. However, the SICCT has been shown to be more 
specific (Buddle et al., 2009; Parsons et al., 2011), and therefore, it may decrease the number of 
cattle that may need further testing using CRAs. 
Another limitation of this study was that cytokine release was only measured starting approximately 
1 week following the SICT. Future research should include measurements of cytokine release pre-
SICT and at scheduled time points after the SICT to determine the relative degree and duration of 
the boosting effect of skin tests on CRAs. Other limitations of the study include a lack of culture 
results for the second study cohort to determine true infection status, and lack of information on 
exposure to environmental mycobacteria.  
In summary, the SICT appeared to cause a boost in IFN-ɣ release in response to bPPD and aPPD 
1 – 3 weeks following the SICT, which decreased significantly thereafter. However, the IFN-ɣ 
response may not be M. bovis-specific, but could reflect a response to environmental 
mycobacteria. In this herd with low BTB prevalence, but suspected high levels of environmental 
mycobacteria, a test or test combination with high specificity would be recommended for future 
herd surveillance. The QFT assays, but not the SICT or the Bovigam® assay, appeared to provide 
more accurate results for cattle in this herd, due to high specificity and ability to differentiate 
between M. bovis infection and sensitisation to environmental mycobacteria. In addition, our results 
Stellenbosch University  https://scholar.sun.ac.za
68 
 
support a recommendation to collect blood for CRAs around 41 days or later, to minimise the effect 
of the SICT on cytokine production.  
5.3 Changes in antigen-induced cytokine release in African buffaloes 
following the SICCT 
In Bovigam®-positive African buffaloes, there was a significant decrease in IFN-ɣ release in 
response to bPPD, and PC-HP and PC-EC peptides, but not to aPPD, 3 days following the SICCT. 
However, the SICCT did not affect IFN-ɣ release in Bovigam®/SICCT-negative buffaloes, which 
agrees with findings from a cattle study (Palmer et al., 2006). Moreover, our findings were similar 
to cattle studies that reported a significant decline in IFN-ɣ release in response to bPPD by 3 days 
post-SICCT (Whelan et al., 2004), between 3 and 7 days post-CFT (Rothel et al., 1992; Wood and 
Rothel, 1994) and 1 – 28 days post-SICCT (ÓNualláin et al., 1997). However, contrary to our 
findings, Thom et al. (2006) found that the SICCT only affected IFN-ɣ release in response to aPPD, 
but not to bPPD. Furthermore, PC-HP and PC-EC peptides contain M. bovis-specific antigens, 
ESAT-6 and CFP-10, and similarly to our study, Whelan et al. (2004) reported a decrease in IFN-ɣ 
release by 3 days post-CFT in response to these antigens in cattle. However, our study did not 
agree with studies that found the TST had no effect on IFN-ɣ release in response to ESAT-6 and 
CFP-10 (Coad et al., 2007; Thom et al., 2006). We also found significantly lower IP-10 release in 
response to PC-EC 3 days after the SICCT in Bovigam®-positive, but not in Bovigam®/ SICCT-
negative animals. To our knowledge, this was the first study that investigated the effect of the 
SICCT on IP-10 release in buffaloes. Following the SICCT, changes in IP-10 release showed 
similar trends to those observed with IFN-ɣ. Furthermore, Bovigam®-positive animals and an 
increase in IFN-ɣ release in response to PPD, PC-HP or PC-EC were observed post-SICCT in a 
cohort of buffaloes (n = 5) that were SICCT-positive, but Bovigam®-negative pre-SICCT (group 3) 
However, this change was not significant. This has also been reported in other studies that found 
that the SICCT detected additional M. bovis-positive animals that were Bovigam®-negative 
(Gormley et al., 2006; Schiller et al., 2010; W. Goosen, pers. comm.). In group 1, the changes in 
IFN-ɣ and IP-10 release were large enough to result in a significant decrease in the proportion of 
Bovigam® PPD, Bovigam® PC-EC and IP-10 (PC-EC) positive buffaloes 3 days post-SICCT. 
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However, the relative test sensitivities of the Bovigam® assays did not change significantly after 
the SICCT were performed, although the relative sensitivity of the IP-10 assay decreased 
significantly.  
Since the TST was associated with a significant decrease in the number of IFN-ɣ and IP-10 
positive animals from pre-SICCT to 3 days post-SICCT, it is possible that the number of false-
negative buffaloes may increase after the SICCT using CRAs. This is especially apparent in the IP-
10 assay, in which the relative test sensitivity decreased significantly at the second test point. 
Therefore, for BTB testing of buffaloes from this herd, we recommend that blood samples for the 
IFN-ɣ and IP-10 CRAs be collected at the time the SICCT is performed, rather than when the 
SICCT response is measured at 3 days. This would also allow identification and removal of greater 
numbers of test-positive animals, which would also improve BTB management in this location 
(HiP), especially since BTB prevalence is very high in certain areas, with reports of up to 54.7% in 
some herds (Jolles et al., 2005; le Roex et al., 2016).  
Environmental mycobacteria have been shown to decrease the sensitivity of assays that use both 
aPPD and bPPD as antigens, since a large aPPD response to environmental mycobacteria may 
mask a bPPD response (Buddle et al., 2009; Parsons et al., 2011; Ryan et al., 2000). Also, a 
change in PPD-specific IFN-ɣ release following the TST may also be in response to environmental 
mycobacteria, rather than to M. bovis, as was seen in our cattle study. However, it is unlikely that 
our results were influenced by exposure to or infection with environmental mycobacteria, since the 
IFN-ɣ response to aPPD was low compared to bPPD. 
Since this study was performed on wild buffaloes, we hypothesised that stress factors affecting 
these animals, including capture by helicopter, captivity, decreased food and water intake, 
handling, fear and new surroundings, may have influenced our results. Studies have shown that 
stress causes a release of glucocorticoids, such as cortisol, which may lead to immune 
suppression and result in significantly reduced tuberculin reactions and IFN-ɣ release in cattle 
(Gormley et al., 2006). Likewise, a significant increase in glucocorticoids upon capture has also 
been reported in zebras (Franceschini et al., 2008) and suppression of T-cell function and 
increased serum cortisol levels in wild ferrets (Cross et al., 1999). However, our results showed 
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that there were no significant changes in cortisol levels between pre- and post-SICCT in the group 
of animals that showed the greatest increase in IFN-ɣ release (group A) or in the group that 
showed the greatest decrease in IFN-ɣ release (group B). There was no significant difference 
between the two groups at either time point, although the mean cortisol concentration in group B 
was higher than that in group A at the pre-SICCT time point and the cortisol concentration 
decreased from pre- to post-SICCT in group B. Nevertheless, our results agreed with Brivio et al. 
(2015) that showed that capture and immobilisation of Alpine ibex did not significantly influence the 
faecal cortisol concentrations, although this was only tested in males. Moreover, it has been shown 
that immune suppression can continue for up to five weeks in deer (Griffin and Thomson, 1998) or 
11 to 18 weeks after release, in zebras (Franceschini et al., 2008). Therefore, cortisol 
concentrations may have already increased by the time of the pre-SICCT measurement and 
remained elevated post-SICCT, which would explain why there was no significant change in 
cortisol concentrations between pre- and post-SICCT samples.  
Chemical immobilisation was performed using etorphine hydrochloride, an opioid that is chemically 
related to morphine. Studies have shown that morphine may result in inhibition of immune 
responses (Garcia et al., 2012; Sacerdote, 2006), which may have contributed to a decline in IFN-ɣ 
release. However, the buffaloes were darted at both sampling sessions, i.e. pre- and post-SICCT, 
and therefore it is unlikely that the opioids caused the decrease in IFN-ɣ that was seen post-
SICCT, since both time points would be influenced by drug administration.   
There were some technical limitations that may have influenced the Bovigam® results. The 
researchers and location where the pre-SICCT Bovigam® assays were performed differed from 
conditions for the post-SICCT assays. The Mabtech IFN-ɣ ELISAs were performed to provide 
confirmation of the results from the Bovigam® assay, since these assays were performed at a 
single location by one person and both time points were performed on the same ELISA plate. The 
Mabtech IFN-ɣ ELISA measured the absolute IFN-ɣ release in response to bPPD, aPPD and PC-
HP peptides and results were in agreement with the Bovigam® assays, suggesting that samples 
were not compromised. Another limitation of this study is that cytokine release was only measured 
at two time points, which limits our understanding of the effect of the SICCT on IFN-ɣ and IP-10 
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release over time. However, due to the logistics and stress involved in capture and immobilisation 
of wild animals, sample collection for cytokine release assays was determined by the schedule for 
performing the SICCT (day 0 and day 3) to avoid additional handling.  
In summary, to our knowledge this is the first study that has investigated the effect of the SICCT on 
cytokine assays in African buffaloes. Our results demonstrated IP-10 and IFN-ɣ release in 
response to specific (PC-HP and PC-EC) and sensitive antigens (PPD) was reduced post-SICCT 
in Bovigam®-positive animals, but remained unchanged in M. bovis-negative animals. The number 
of IFN-ɣ and IP-10 positive buffaloes and the relative sensitivity of the IP-10 assay decreased 3 
days following the SICCT. In a herd with high M. bovis infection rates, effective BTB management 
efforts requires removal of as many infected buffaloes as possible. Based on our results, we 
recommend that blood samples be collected for the IP-10 and IFN-ɣ CRAs on the day the SICCT is 
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Chapter 6: Conclusion 
The accurate detection of M. bovis infected buffaloes has been shown to be influenced by the 
stage of infection. Although no significant changes in CMI responses or circulating antibodies were 
observed in our first study over a 1 year period, it appeared that the accurate detection of M. bovis-
infected buffaloes depended on the cytokine measured and the particular antigen used for whole 
blood stimulation. Buffaloes that may have been at early stages of infection, were identified by IP-
10 assays but not by those measuring IFN-ɣ. Although both Bovigam® PPD and QFT assays were 
able to identify infected animals over time, QFT assays, using ESAT-6 and CFP-10, were more 
appropriate diagnostic assays than the Bovigam® PPD assay to use for animals exposed to 
environmental mycobacteria. However, in terms of changes in antigen-specific responses in 
individual infected buffaloes, we did not find obvious trends during the study period and further 
studies are needed to investigate changes in immunological responses that may affect diagnostic 
outcomes over time. 
The SICT has been shown to affect IFN-ɣ and IP-10 production in cattle. PPD-specific cytokine 
production remained elevated 1-3 weeks following the SICT, which declined significantly by 41 
days post-SICT. However, the effect was variable in response to ESAT-6/CFP-10, since cytokine 
release decreased between 6 and 41 days post-SICT in group 1, but remained unchanged 
between 7, 21 and 78 days in group 2. However, it appears as though immunological boosting of 
cytokine release may not be M. bovis-specific, but could reflect a cross-reactive response to 
environmental mycobacteria. This was supported by the large number of false-positive cattle 
detected by Bovigam® compared to the significantly lower number of QFT-positive cattle at 41 
days post-SICT, at which point the effect of the SICT had significantly subsided. QFT assay results 
were not affected by environmental mycobacteria and correctly identified the animals from group 1 
as test-negative at 41 days post-SICT. It is therefore recommended that cattle from areas with high 
environmental mycobacterial burden and low BTB incidence be tested with assays of high 
specificity, i.e. QFT assays, at 41 days or later after the application of the SICT.  
In M. bovis-infected buffaloes, IFN-ɣ and IP-10 release and the number of test positive animals 
decreased significantly 3 days following the SICCT. However, since HiP has a high incidence of 
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BTB in buffaloes, the aim is to remove all possible test-positive buffaloes from the herd. Therefore, 
we recommend taking blood samples on the day the SICCT is performed, rather than 3 days later. 
No change in cytokine release in M. bovis-uninfected buffaloes following the SICCT was observed.  
Accuracy of ante-mortem diagnostic assays may be influenced by many factors, including the 
stage of M. bovis infection, exposure to environmental mycobacteria, differing high M. bovis 
prevalence, and performance of TSTs prior to in vitro immunological assays. Our study has shown 
that assays using specific antigens, ESAT-6 and CFP-10, improves the accuracy of detection in 
cattle herds with low BTB incidence and high environmental mycobacteria exposure, especially 
when the effect of the SICT has subsided by 41 days post-SICT. However, in buffalo herds with 
high BTB incidence, highly sensitive assays are required to identify all M. bovis-positive animals 
and CRAs have been shown to be significantly more sensitive before the SICCT is performed.    
This was the first study that investigated the temporal changes in immune responses and the effect 
of the TST in African buffaloes. Also, to our knowledge, this was the first study to describe the 
effect of the TST on IP-10 production. This study contributed to improving our understanding of 
changes of immunological responses over time in buffaloes, the effects of environmental 
mycobacteria on the interpretation of ante-mortem diagnostic assays and the effect of the TST on 
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